Bronchiectasis

J10_BRONCHIECTASIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J47 Hospital discharge: ICD-9 — 494 Hospital discharge: ICD-8 — 51899 Cause of death: ICD-10 — J47 Cause of death: ICD-9 — 494 Cause of death: ICD-8 — 51899 2 out of 7 registries used, show all original rules.	3017
4. Check minimum number of events None	3017
5. Include endpoints None	3017
6. Filter based on genotype QC (FinnGen only)	3017

Control definitions (FinnGen only)

Control exclude: J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Bronchiectasia

NAME	J10_BRONCHIECTASIS
CONTROL_EXCLUDE	J10_LOWCHRON
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J47
HD_ICD_9	494
HD_ICD_8	51899
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J47
COD_ICD_9	494
COD_ICD_8	51899
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bronchiectasis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19660	10773	8661
Only index persons	15964	9233	6731
Unadjusted period prevalence (%)
Whole population	0.28	0.31	0.24
Only index persons	0.30	0.34	0.26
Median age at first event (years)
Whole population	64.04	63.59	64.67
Only index persons	63.90	63.42	64.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3017	1662	1355
Unadjusted period prevalence (%)	0.58	0.57	0.60
Median age at first event (years)	63.55	62.19	65.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2686: Matched controls
26859

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J45

ICD-10 Finland

Asthma

26.2

323.0

471

216

R03AC12

ATC

salmeterol; inhalant

75.3

323.0

426

R03BB04

ATC

tiotropium bromide; inhalant

48.1

323.0

1038

347

J18.9

ICD-10 Finland

Pneumonia, unspecified

6.9

323.0

1452

3923

J01MA14

ATC

moxifloxacin; systemic

12.0

323.0

820

947

J45.1

ICD-10 Finland

Nonallergic asthma

471.5

323.0

625

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

23.4

323.0

726

418

J45.0

ICD-10 Finland

Predominantly allergic asthma

178.2

323.0

553

UGC12

NOMESCO Finland

Flexible bronchoscopy

15.4

323.0

893

843

R03DC03

ATC

montelukast; oral

14.1

323.0

916

949

J47

ICD-10 Finland

Bronchiectasis

4503599627370496.0

323.0

2498

R03AC02

ATC

salbutamol; inhalant

10.2

323.0

2122

7216

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

44.6

323.0

550

154

H02AB06

ATC

prednisolone; systemic

6.6

323.0

1931

7534

R03BA01

ATC

beclometasone; inhalant

10.7

323.0

729

906

R03BA02

ATC

budesonide; inhalant

9.5

323.0

837

1225

R03DA04

ATC

theophylline; systemic, rectal

30.5

323.0

468

184

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

323.0

1205

R03AK06

ATC

salmeterol and fluticasone; inhalant

23.3

323.0

985

651

R03BA05

ATC

fluticasone; inhalant

10.1

323.0

950

1377

J45.9

ICD-10 Finland

Asthma, unspecified

81.7

323.0

1183

256

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

8.5

316.4

774

1217

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

178.8

305.5

316

R03AK08

ATC

formoterol and beclometasone; inhalant

64.3

299.5

348

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

6.1

293.6

959

2238

R03AK07

ATC

formoterol and budesonide; inhalant

7.3

284.7

776

1412

J01FA06

ATC

roxithromycin; oral

4.4

281.3

1598

6682

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

21.7

280.9

424

230

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

15.5

277.7

478

370

51899

ICD-8 Finland

Bronchiectasis

+∞

274.8

259

R96

ICPC

Asthma

18.9

274.7

436

273

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

8.1

267.7

667

1050

R03BA08

ATC

ciclesonide; inhalant

14.5

260.8

462

380

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

4.2

258.8

1758

8413

R03AC13

ATC

formoterol; inhalant

34.2

256.9

339

113

J45.8

ICD-10 Finland

Mixed asthma

355.2

256.0

255

J46

ICD-10 Finland

Status asthmaticus

355.2

256.0

255

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

237.9

1760

8783

J01AA02

ATC

doxycycline; systemic

5.8

231.7

2419

16408

R03AC03

ATC

terbutaline; inhalant

7.4

231.6

614

1040

R05

ICD-10 Finland

Cough

4.6

225.2

961

2876

R03BB01

ATC

ipratropium bromide; inhalant

20.2

223.0

344

194

J01MA12

ATC

levofloxacin; systemic

4.4

213.1

952

2951

R04.2

ICD-10 Finland

Haemoptysis

14.3

205.5

364

292

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

12.6

192.8

362

329

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

12.2

191.8

366

344

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

69.6

189.7

218

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

181.3

172

R03AK11

ATC

formoterol and fluticasone; inhalant

57.1

177.9

211

XG474

NOMESCO Finland

Exhalation nntrogen oxide

31.5

174.2

234

J01FA10

ATC

azithromycin; systemic

3.2

171.1

1713

9616

XG410

NOMESCO Finland

Flow-volume spirometry

12.4

170.9

322

292

TGC00

NOMESCO Finland

Bronchial lavation

14.2

169.5

299

234

H02AB07

ATC

prednisone; oral

4.6

165.1

664

1787

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

7.5

164.9

418

640

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.6

164.4

415

631

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

131.9

162.3

173

R06.0

ICD-10 Finland

Dyspnoea

3.4

155.0

975

3845

J01FA09

ATC

clarithromycin; systemic

3.2

154.3

1095

4716

H02AB04

ATC

methylprednisolone; systemic

4.4

153.1

637

1758

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

154.5

152.1

160

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

24.5

148.0

213

49300

ICD-8 Finland

Asthma, bronchiale

+∞

144.0

137

TDM10

NOMESCO Finland

Puncture of maxillary antrum

11.3

131.6

258

250

R01AD09

ATC

mometasone; nasal

2.7

123.2

1300

6946

J01FA15

ATC

telithromycin; oral

4.8

122.3

452

1084

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

8.5

121.1

280

364

J01CA04

ATC

amoxicillin; systemic

3.0

118.8

2224

16452

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

251.0

117.8

120

J20

ICD-10 Finland

Acute bronchitis

4.6

114.5

438

1084

R01AD08

ATC

fluticasone; nasal

2.9

112.6

886

3901

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

201.9

112.4

116

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

82.0

111.3

125

R05

ICPC

Cough

3.0

111.0

793

3270

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

6.9

110.8

295

473

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.2

106.7

233

274

GD1AD

NOMESCO Finland

Thorax CT examination

6.7

105.0

286

472

R02

ICPC

Shortness of breath/dyspnoea

3.9

104.9

492

1466

R03DC01

ATC

zafirlukast; oral

36.2

101.2

131

UDH02

NOMESCO Finland

Rhinopharyngoscopy

5.3

93.7

308

640

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

93.3

J96.1

ICD-10 Finland

Chronic respiratory failure

19.6

91.0

140

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.9

90.1

644

2604

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

10.9

89.1

176

171

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

62.3

87.4

102

XQ800

NOMESCO Finland

Prick test

5.5

85.0

267

524

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.4

85.0

1033

5613

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

9.8

84.7

177

191

R81

ICPC

Pneumonia

7.1

84.7

218

330

J43.9

ICD-10 Finland

Emphysema, unspecified

104.6

83.4

J42

ICD-10 Finland

Unspecified chronic bronchitis

25.9

79.6

112

A02BC02

ATC

pantoprazole; systemic

2.2

79.5

1883

13755

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

11.7

77.8

148

133

J01MA02

ATC

ciprofloxacin; systemic

2.2

75.1

1228

7538

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.4

74.8

810

4094

R01AD01

ATC

beclometasone; nasal

2.9

71.3

489

1890

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

71.1

704

3381

R01AD05

ATC

budesonide; nasal

4.1

70.7

296

780

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

149.9

69.3

A03

ICPC

Fever

3.0

67.6

442

1650

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

67.1

1140

7004

J31.0

ICD-10 Finland

Chronic rhinitis

4.1

66.5

284

761

XG405

NOMESCO Finland

Education on PEF monitoring

21.8

65.6

R06.2

ICD-10 Finland

Wheezing

6.6

64.5

173

276

R01AD12

ATC

fluticasone furoate; nasal

2.3

63.8

729

3729

J32.4

ICD-10 Finland

Chronic pansinusitis

18.2

63.6

100

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

6.4

63.1

173

284

R95

ICPC

Chron obstructive pulmonary disease

14.6

63.0

108

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.6

62.7

528

2296

R05CB01

ATC

acetylcysteine; inhalant, oral

11.4

62.0

119

109

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

61.7

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

9.3

61.5

132

149

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

78.7

61.3

J01DA01

ATC

[U] cefalexin; systemic

2.0

61.0

1675

12252

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

20.9

60.8

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

8.4

60.7

138

172

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

52.8

60.2

J01DB01

ATC

cefalexin; oral

2.2

59.5

2153

17484

SPAT1325

SPAT

Vaccination

2.0

59.2

1133

7191

A02BC05

ATC

esomeprazole; systemic

2.0

58.9

1161

7449

J01DA06

ATC

[U] cefuroxime; systemic

2.6

58.0

480

2060

120

Kela drug reimbursment

Hypogammaglobulinaemia

150.7

56.1

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.1

55.2

750

4106

A01AB09

ATC

miconazole; local oral

3.0

55.0

344

1235

49099

ICD-8 Finland

Bronchitis, unspecified

+∞

54.3

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

190.5

54.1

A07AA02

ATC

nystatin; oral

3.5

52.2

267

828

WW200

NOMESCO Finland

Immunization

6.1

51.7

147

253

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.2

51.6

298

1012

R06AE07

ATC

cetirizine; oral

1.9

51.4

1083

7011

R50.9

ICD-10 Finland

Fever, unspecified

2.5

50.5

446

1970

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

50.1

J02AC01

ATC

fluconazole; systemic

1.9

50.1

1010

6420

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

49.6

885

5368

R03BC03

ATC

nedocromil; inhalant

3.5

49.4

248

756

R01BA52

ATC

pseudoephedrine, combinations; oral

2.0

49.2

822

4858

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

49.1

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.2

48.8

122

176

M05BA04

ATC

alendronic acid; oral

2.7

48.8

367

1478

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

6.9

47.9

124

188

C03CA01

ATC

furosemide; systemic

1.9

47.5

948

5969

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.2

47.2

270

906

R29

ICPC

Respiratory symptom/complaint other

3.8

47.1

216

611

J01DA08

ATC

[U] cefaclor; oral

3.0

46.9

296

1065

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

8.5

46.8

105

128

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

46.0

R05FB02

ATC

cough suppressants and expectorants

1.8

45.8

1095

7320

R28

ICPC

Limited function/disability (R)

12.0

44.8

1240

FHL

Bronchoscopy

12.2

44.6

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

44.3

638

3523

XG466

NOMESCO Finland

Sleep oxymetry

5.6

44.3

134

249

A02BC03

ATC

lansoprazole; oral

1.9

43.7

863

5377

A02BC01

ATC

omeprazole; systemic

1.9

43.4

822

5039

J01FF01

ATC

clindamycin; systemic

1.9

43.0

745

4418

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

152.4

42.9

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

42.1

545

2872

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

41.8

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

13.1

41.6

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

11.3

41.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

41.4

305

1208

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

16.3

41.3

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.6

41.1

197

577

R05FA02

ATC

opium derivatives and expectorants; systemic

1.8

40.9

1099

7548

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

40.7

R06AX27

ATC

desloratadine; oral

2.0

40.2

589

3258

N02AX02

ATC

tramadol; systemic, rectal

1.8

40.2

1136

7912

R74

ICPC

Upper respiratory infection acute

2.0

40.0

591

3284

J01DC02

ATC

cefuroxime; systemic

3.5

39.7

194

577

R5140

NOMESCO Finland

Monitoring the use of the aid

2.6

39.3

312

1288

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.9

39.2

254

927

ZXA10

NOMESCO Finland

Bilateral

2.0

39.2

601

3385

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

38.8

478

2456

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

38.7

358

1604

A02BA02

ATC

ranitidine; systemic

2.0

38.7

611

3477

R03BB02

ATC

oxitropium bromide; inhalant

33.9

38.5

G47.3

ICD-10 Finland

Sleep apnoea

2.1

38.3

530

2857

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

10.3

38.0

B05XA03

ATC

sodium chloride; parenteral

+∞

37.6

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

37.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

37.3

797

5045

SPAT1263

SPAT

Sampling

1.7

36.3

1154

8243

R03BC01

ATC

cromoglicic acid; inhalant

15.4

35.7

J33.0

ICD-10 Finland

Polyp of nasal cavity

5.4

35.2

109

209

SPAT1254

SPAT

Administration of medicine

2.1

35.1

449

2335

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

43.6

35.0

R03BB07

ATC

umeclidinium bromide; inhalant

37.2

34.7

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.9

34.7

100

176

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

18.6

34.4

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

+∞

34.4

R4110

NOMESCO Finland

Physiotherapy

1.8

34.2

751

4768

SPAT1058

SPAT

PEF monitoring instruction

2.8

34.2

230

858

R06AX13

ATC

loratadine; oral

2.3

34.0

360

1720

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

33.4

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

+∞

33.4

R09.3

ICD-10 Finland

Abnormal sputum

9.0

33.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

33.0

350

1669

WZC30

NOMESCO Finland

Teaching

2.2

32.5

386

1938

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

7.1

32.1

116

N02BE01

ATC

paracetamol; systemic, rectal

1.9

32.0

2263

19940

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

31.6

507

2875

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

48.1

31.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

31.3

411

2153

R01AD11

ATC

triamcinolone; nasal

2.6

31.0

243

992

SPAT1059

SPAT

Spirometry at the office

3.7

31.0

141

396

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

30.9

347

1698

P01BA02

ATC

hydroxychloroquine; oral

2.5

30.8

268

1155

R03AC18

ATC

indacaterol; inhalant

46.8

30.6

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

8.4

30.5

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.8

30.5

203

750

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

31.2

30.4

49102

ICD-8 Finland

Chronic bronchitis, Purulenta

+∞

30.3

H65.3

ICD-10 Finland

Chronic mucoid otitis media

6.4

29.9

128

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

29.7

1172

8719

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

156.7

29.7

A01AB04

ATC

amphotericin B; local oral

3.0

29.3

178

619

J41.0

ICD-10 Finland

Simple chronic bronchitis

37.5

29.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

29.2

462

2596

J33.8

ICD-10 Finland

Other polyp of sinus

6.1

28.8

135

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

23.9

28.3

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

55.6

28.2

UDM02

NOMESCO Finland

Sinoscopy

5.4

28.1

163

R06AX22

ATC

ebastine; oral

2.0

27.7

388

2078

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

11.0

27.3

H02AB09

ATC

hydrocortisone; systemic

4.7

27.2

204

J01XB01

ATC

colistin; inhalant, parenteral

+∞

27.1

C07AB07

ATC

bisoprolol; oral

1.6

27.0

1326

10326

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

8.3

26.8

J01FA01

ATC

erythromycin; systemic

2.2

26.6

309

1528

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.6

26.6

145

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

26.5

385

2091

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

26.3

620

3969

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.6

26.3

212

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

7.5

26.1

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

26.1

R78

ICPC

Acute bronchitis/bronchiolitis

4.6

26.0

201

J37.0

ICD-10 Finland

Chronic laryngitis

4.1

25.8

103

258

C01CA24

ATC

epinephrine; parenteral

3.3

25.8

137

435

P01AB01

ATC

metronidazole; oral, rectal

1.6

25.7

948

6852

N03AX16

ATC

pregabalin; oral

1.7

25.6

611

3925

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

25.5

192

763

R99

ICPC

Respiratory disease other

5.3

25.4

153

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.1

25.3

143

474

ZX120

NOMESCO Finland

Intravenous

2.2

25.2

290

1428

348

Kela drug reimbursment

Roflumilast

+∞

25.0

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

25.0

200

825

S01GX01

ATC

cromoglicic acid; ophthalmic

1.9

24.9

420

2406

J15.8

ICD-10 Finland

Other bacterial pneumonia

11.7

24.9

R24

ICPC

Haemoptysis

12.0

24.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

24.7

367

2008

R06AE09

ATC

levocetirizine; oral

2.1

24.6

310

1587

N05CF01

ATC

zopiclone; oral

1.6

24.5

873

6238

L04AX01

ATC

azathioprine; systemic

3.1

24.5

139

462

6BA02

NOMESCO Finland

17.5

24.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

24.2

534

3338

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

23.9

404

2314

48609

ICD-8 Finland

Pneumonia, unspecified

6.9

23.8

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

242.0

23.7

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

41.8

23.6

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

23.5

267

1306

R06AX26

ATC

fexofenadine; oral

2.8

23.5

156

577

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

23.3

686

4651

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.9

23.2

259

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

23.1

829

5915

R79

ICPC

Chronic bronchitis

32.5

22.4

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

8.7

22.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.2

1111

8545

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

22.1

509

3215

R05CB03

ATC

carbocisteine; oral

4.1

22.1

216

J98.1

ICD-10 Finland

Pulmonary collapse

11.9

22.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.9

1086

8330

UJF32

NOMESCO Finland

Coloscopy

1.6

21.9

703

4863

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

21.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

21.8

283

1462

E0000UV

ATC

1.5

21.8

917

6779

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.5

21.7

121

L28

ICPC

Limited function/disability (L)

1.7

21.6

472

2934

R03AC19

ATC

olodaterol; inhalant

115.9

21.6

J01MA01

ATC

ofloxacin; systemic

2.1

21.5

253

1254

H65.2

ICD-10 Finland

Chronic serous otitis media

6.2

21.5

DPA30

NOMESCO Finland

Sphenotomy

15.4

21.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

21.5

681

4691

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

21.3

179

756

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.3

21.2

108

333

N03AX12

ATC

gabapentin; oral

1.8

21.2

385

2252

R03BB06

ATC

glycopyrronium bromide; inhalant

50.4

21.1

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

34.1

21.1

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

10.4

21.1

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

8.8

21.1

4222

FHL

Endonasal etmoidectomy

11.3

20.9

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

60.5

20.9

R03DX07

ATC

roflumilast; oral

+∞

20.9

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.1

20.7

252

1269

R03BB05

ATC

aclidinium bromide; inhalant

77.4

20.7

SPAT1260

SPAT

Consultation of another employee

1.7

20.7

476

3002

SPAT1255

SPAT

Intravenous administration of medicine

2.3

20.7

205

941

J43.8

ICD-10 Finland

Other emphysema

211.5

20.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

20.5

331

1860

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.0

20.5

E000001

ATC

1.7

20.2

478

3035

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

5.2

20.1

124

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

20.1

221

1065

DHB20

NOMESCO Finland

Polypectomy of internal nose

6.0

20.0

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.6

19.9

258

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

19.8

4911A

ICD-9 Finland

Chronic bronchitis, Mucopurulent chronic bronchitis

+∞

19.8

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

19.8

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

6.7

19.7

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

29.1

19.6

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

105.8

19.6

R01AC01

ATC

cromoglicic acid; nasal

3.8

19.5

227

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

19.3

258

1346

WX725

NOMESCO Finland

Noninvasive ventilation

2.8

19.3

130

484

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

19.2

627

4335

R53

ICD-10 Finland

Malaise and fatigue

1.6

19.1

514

3382

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

55.4

18.9

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

16.0

18.8

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

18.7

283

1550

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

12.4

18.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

18.6

165

718

RF410

NOMESCO Finland

5.8

18.4

R05CA10

ATC

expectorants - combinations

3.7

18.3

219

J30.3

ICD-10 Finland

Other allergic rhinitis

4.0

18.3

190

A46

ICD-10 Finland

Erysipelas

1.8

18.3

368

2220

48509

ICD-8 Finland

Bronchopneumonia, unspecified

6.9

18.2

78310

ICD-8 Finland

Symptoms referable to respiratory system, Haemoptysis

19.5

18.2

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

18.1

220

1105

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

18.0

966

7441

S18

ICPC

Laceration/cut

1.4

17.9

1077

8487

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

17.9

469

3054

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

67.0

17.7

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

67.0

17.7

A04

ICPC

Weakness/tiredness general

1.8

17.6

341

2032

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

17.6

203

998

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

5.4

17.4

R05CB02

ATC

bromhexine; systemic

4.7

17.4

128

WX892

NOMESCO Finland

Monitored bed care

2.1

17.3

208

1040

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

17.3

284

A06AD11

ATC

lactulose; oral

1.7

17.2

408

2580

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.1

17.1

329

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

6.3

17.1

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

17.1

369

2269

N02AA05

ATC

oxycodone; systemic

1.7

17.0

409

2600

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

17.0

222

1150

J02AC03

ATC

voriconazole; systemic

17.5

16.9

UDC00

NOMESCO Finland

Ear microscopy

2.1

16.9

198

982

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

16.8

774

5755

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

16.7

210

1071

R42

ICD-10 Finland

Dizziness and giddiness

1.5

16.7

595

4182

N06AB04

ATC

citalopram; systemic

1.6

16.7

494

3316

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.4

16.7

248

Y0499

ICD-8 Finland

Investigation of respiratory system

5.1

16.7

103

R04

ICPC

Breathing problem other

3.1

16.6

298

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

16.6

761

5656

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

16.6

946

7348

L88

ICPC

Rheumatoid/seropositive arthritis

2.6

16.5

119

464

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

16.5

640

4587

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

16.2

209

1077

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.0

16.2

204

1039

M79.6

ICD-10 Finland

Pain in limb

1.5

16.2

834

6341

N06AX11

ATC

mirtazapine; oral

1.5

16.2

727

5372

A01AB10

ATC

natamycin; local oral

3.2

16.1

277

F2680

NOMESCO Finland

30.2

16.1

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.7

16.0

117

RF210

NOMESCO Finland

3.1

15.9

280

R60.0

ICD-10 Finland

Localized oedema

1.8

15.8

295

1736

C08DA01

ATC

verapamil; systemic

2.5

15.8

125

514

JN4BD

NOMESCO Finland

Extensive body CT

1.8

15.7

311

1862

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.6

15.7

119

R13

ICD-10 Finland

Dysphagia

2.1

15.7

176

854

J32.8

ICD-10 Finland

Other chronic sinusitis

15.7

Q89.34

ICD-10 Finland

Cartagena syndrome (immotile cilia)

+∞

15.6

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

17.3

15.6

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

7.9

15.6

R51.80

ICD-10 Finland

Headache

1.8

15.5

289

1698

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

10.1

15.4

S22.3

ICD-10 Finland

Fracture of rib

2.2

15.3

166

795

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

15.2

203

1061

A31.9

ICD-10 Finland

Mycobacterial infection, unspecified

45.2

15.1

J01MA11

ATC

grepafloxacin; oral

45.2

15.1

SPAT1216

SPAT

Assessment of functional ability

1.6

15.0

444

2971

M54.5

ICD-10 Finland

Low back pain

1.5

15.0

711

5296

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.4

14.9

L04AA13

ATC

leflunomide; oral

3.1

14.9

270

RK110

NOMESCO Finland

7.0

14.8

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

14.8

395

2574

M05BX04

ATC

denosumab; parenteral

2.1

14.8

165

799

4224

FHL

Endonasal anthrostomy

6.0

14.8

J96.0

ICD-10 Finland

Acute respiratory failure

4.9

14.8

100

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

8.7

14.7

J05AB11

ATC

valaciclovir; oral

1.7

14.7

321

1979

A02BC04

ATC

rabeprazole; oral

2.0

14.7

203

1075

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.0

14.7

283

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

14.6

411

2716

-1

NOMESCO Finland

1.5

14.6

663

4892

3028

Kela drug reimbursment

Mepolizumab

+∞

14.6

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

80.5

14.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

14.5

912

7164

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

14.5

283

1685

R09

ICPC

Sinus symptom/complaint

2.1

14.5

158

759

WX722

NOMESCO Finland

PEEP

2.4

14.5

124

530

AA1AD

NOMESCO Finland

CT of head and brain

1.5

14.4

635

4657

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

14.4

368

2373

SPAT1262

SPAT

Handing over of treatment supplies

1.6

14.3

476

3274

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

14.3

114

469

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.3

736

5565

R49.08

ICD-10 Finland

Other specified dysphonia

3.7

14.3

171

Z71.8

ICD-10 Finland

Other specified counselling

1.5

14.3

497

3458

N06AA09

ATC

amitriptyline; systemic

1.8

14.2

260

1516

RF420

NOMESCO Finland

4.4

14.2

114

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

14.2

1516

13039

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

42.7

14.1

J01.1

ICD-10 Finland

Acute frontal sinusitis

5.1

14.1

L03

ICPC

Low back symptom/complaint

1.5

14.1

550

3928

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

14.0

130

579

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

14.0

367

2379

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

14.0

268

1588

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

13.9

103

409

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.8

13.9

319

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

13.9

271

1617

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

6.5

13.8

SPAT1057

SPAT

Peak expiratory flow measurement

4.0

13.8

136

A03FA02

ATC

cisapride; oral, rectal

1.9

13.8

217

1205

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

8.6

13.7

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

13.7

173

885

RK250

NOMESCO Finland

10.5

13.7

J32.1

ICD-10 Finland

Chronic frontal sinusitis

13.6

13.7

J05AH02

ATC

oseltamivir; oral

9.1

13.7

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

13.7

234

1334

N05BA01

ATC

diazepam; systemic, rectal

1.7

13.6

315

1975

R03DX09

ATC

mepolizumab; parenteral

+∞

13.5

297

Kela drug reimbursment

+∞

13.5

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

13.5

N05BA04

ATC

oxazepam; oral

1.5

13.5

556

4010

B44.8

ICD-10 Finland

Other forms of aspergillosis

140.6

13.5

RK320

NOMESCO Finland

6.1

13.5

L04AA01

ATC

[U] ciclosporin; systemic

3.9

13.4

140

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

13.3

417

2826

R03AC04

ATC

fenoterol; inhalant

21.2

13.3

J86.9

ICD-10 Finland

Pyothorax without fistula

6.0

13.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

13.2

237

1375

J05AB01

ATC

aciclovir; systemic

1.5

13.1

475

3330

R49.01

ICD-10 Finland

Functional dysphonia

2.9

13.1

288

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

13.1

105

436

WX110

NOMESCO Finland

Local anesthesy

1.4

13.1

1526

13222

J34.2

ICD-10 Finland

Deviated nasal septum

2.4

13.1

108

456

DHA10

NOMESCO Finland

Biopsy of cavity of nose

5.8

13.0

4239

FHL

Other measure in this category

9.4

12.9

SPAT1301

SPAT

No procedures

1.4

12.9

794

6181

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

12.9

215

1216

D72.1

ICD-10 Finland

Eosinophilia

13.0

12.9

J01DC04

ATC

cefaclor; oral

4.7

12.9

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.6

12.9

383

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

6.1

12.9

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

11.6

12.8

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

11.6

12.8

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.3

12.8

116

512

XG460

NOMESCO Finland

Short time oxymetry

4.0

12.7

127

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.7

788

6145

R03CC02

ATC

salbutamol; systemic

2.9

12.7

277

M05BA07

ATC

risedronic acid; oral

2.4

12.6

108

465

4226

FHL

Posterior radical surgery and possible etmoidectomy

6.5

12.6

A28

ICPC

Limited function/disability NOS

1.5

12.5

428

2956

L17

ICPC

Foot/toe symptom/complaint

1.4

12.5

612

4566

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

12.4

177

946

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.4

1335

11378

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

12.3

483

3438

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.5

12.3

167

I50.0

ICD-10 Finland

Congestive heart failure

1.8

12.2

198

1111

L04AA06

ATC

mycophenolic acid; systemic

3.8

12.1

133

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

7.0

12.1

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

9.3

12.0

-44

ICPC

Preventive immunization/medic

1.7

11.9

233

1390

A02BA04

ATC

nizatidine; systemic

1.8

11.9

212

1229

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.9

11.9

K02.1

ICD-10 Finland

Caries of dentine

1.3

11.8

1139

9521

A02BA03

ATC

famotidine; systemic

2.3

11.8

112

506

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

11.7

561

4160

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

11.7

331

2186

B37.0

ICD-10 Finland

Candidal stomatitis

5.2

11.6

R75

ICPC

Sinusitis acute/chronic

2.4

11.6

410

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

11.6

144

731

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

7.7

11.6

J18

ICD-10 Finland

Pneumonia, organism unspecified

5.6

11.6

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.8

11.6

258

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

11.6

131

643

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

11.5

788

6225

R83

ICPC

Respiratory infection other

1.5

11.5

367

2492

G44.2

ICD-10 Finland

Tension-type headache

1.7

11.5

268

1683

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

11.5

193

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

+∞

11.5

J01EA01

ATC

trimethoprim; systemic

1.4

11.4

623

4727

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

11.4

1161

9762

M48.0

ICD-10 Finland

Spinal stenosis

1.6

11.4

321

2114

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

11.4

191

1085

D07AA02

ATC

hydrocortisone; topical

1.6

11.4

273

1727

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.3

11.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.2

11.2

R01

ICPC

Pain respiratory system

4.2

11.2

R05DB20

ATC

other cough suppressants - combinations

2.1

11.2

128

630

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

11.2

1159

9765

N06AX21

ATC

duloxetine; oral

1.8

11.1

212

1252

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.7

11.1

219

1308

R11

ICD-10 Finland

Nausea and vomiting

1.8

11.1

182

1025

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

7.6

11.1

RF120

NOMESCO Finland

4.5

11.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

11.1

980

8055

R07.3

ICD-10 Finland

Other chest pain

1.7

11.1

222

1334

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

11.1

563

4219

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

11.0

122

592

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

5.8

11.0

I45.9

ICD-10 Finland

Conduction disorder, unspecified

5.6

11.0

DHB50

NOMESCO Finland

Turbinoplasty

3.2

11.0

172

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

13.9

11.0

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

10.9

307

K59.0

ICD-10 Finland

Constipation

1.9

10.8

147

776

R04.0

ICD-10 Finland

Epistaxis

1.8

10.8

195

1133

N17

ICPC

Vertigo/dizziness

1.6

10.7

282

1824

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

17.9

10.7

R35

ICD-10 Finland

Polyuria

1.9

10.7

161

879

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

4.1

10.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

10.7

397

2791

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.2

10.6

176

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

60.2

10.6

R03DA05

ATC

aminophylline; systemic, rectal

6.3

10.6

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.3

10.6

155

UJD02

NOMESCO Finland

Gastroscopy

2.0

10.6

128

646

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.5

492

3621

L95

ICPC

Osteoporosis

2.2

10.5

101

460

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.0

10.5

140

734

UKC02

NOMESCO Finland

Cystoscopy

1.5

10.5

427

3058

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

9.2

10.5

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

10.4

753

5984

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

10.4

256

1628

49309

ICD-8 Finland

Asthma, Unspecified

+∞

10.4

R91

ICPC

CHRONIC BRONCHITIS

+∞

10.4

J43.1

ICD-10 Finland

Panlobular emphysema

+∞

10.4

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

+∞

10.4

A99

ICPC

Disease/condition unspecnature/site

1.7

10.4

202

1202

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.6

10.3

273

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

16.1

10.3

D80.2

ICD-10 Finland

Selective deficiency of immunoglobulin A [IgA]

32.6

10.3

E000007

ATC

2.1

10.3

117

575

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

10.2

401

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

7.5

10.2

R4120

NOMESCO Finland

Occupational therapy

1.9

10.1

146

787

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

10.0

138

734

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

9.9

374

J01AA07

ATC

tetracycline; systemic

1.6

9.9

273

1792

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

6.3

9.8

N05CD07

ATC

temazepam; oral

1.5

9.8

321

2192

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

26.1

9.8

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

9.8

269

1760

B01AF02

ATC

apixaban; oral

1.6

9.8

269

1762

Z00.0

ICD-10 Finland

General medical examination

1.5

9.8

415

2995

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.4

9.7

340

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.6

9.7

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

9.7

223

1394

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

55.2

9.6

M01AH02

ATC

rofecoxib; oral

1.5

9.6

340

2360

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.6

905

7466

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

9.6

156

877

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

9.6

525

3974

B01AA03

ATC

warfarin; systemic

1.4

9.5

548

4186

GDA10

NOMESCO Finland

Biopsy of lung

15.1

9.5

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

5.7

9.5

C01DA14

ATC

isosorbide mononitrate; oral

1.4

9.5

423

3081

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

100.3

9.4

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.4

737

5914

H01

ICPC

Ear pain/earache

1.7

9.4

203

1248

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

9.4

366

2597

RF220

NOMESCO Finland

3.4

9.4

132

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

+∞

9.4

J02AC02

ATC

itraconazole; systemic

1.5

9.4

386

2767

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

9.3

112

565

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

9.3

149

D07AC13

ATC

mometasone; topical

1.4

9.3

618

4832

R01AC07

ATC

nedocromil; nasal

9.5

9.3

UGC02

NOMESCO Finland

Rigid bronchoscopy

9.5

9.3

R03CC03

ATC

terbutaline; systemic

4.5

9.3

R06.5

ICD-10 Finland

Mouth breathing

1.8

9.2

167

972

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

9.2

141

776

318

Kela drug reimbursment

Teriparatide

5.7

9.2

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

9.2

529

4039

L04AD01

ATC

ciclosporin; systemic

3.1

9.2

151

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

9.2

477

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.8

9.1

Z50.1

ICD-10 Finland

Other physical therapy

1.9

9.1

137

751

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

7.7

9.1

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.1

615

4820

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.6

9.1

245

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.7

9.0

231

284

Kela drug reimbursment

Nintedanib and pirfenidone

5.9

9.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

9.0

721

5799

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

9.0

550

4240

Y3409

ICD-8 Finland

Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis

18.6

8.9

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

24.1

8.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

8.9

160

930

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.8

382

2761

R03

ICPC

Wheezing

4.4

8.8

GD1AA

SPAT

2.0

8.8

104

523

M79.1

ICD-10 Finland

Myalgia

1.6

8.8

260

1736

SPAT1036

SPAT

Maxillary puncture

9.5

8.8

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

7.2

8.7

ZXA05

NOMESCO Finland

Left side

1.3

8.7

641

5086

B02AA02

ATC

tranexamic acid; systemic

1.5

8.7

278

1888

M25.5

ICD-10 Finland

Pain in joint

1.4

8.7

576

4497

J67.0

ICD-10 Finland

Farmer lung

14.1

8.7

ZXA00

NOMESCO Finland

Right side

1.3

8.6

678

5431

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

6.6

8.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

8.6

254

1692

M04AA01

ATC

allopurinol; systemic

1.5

8.6

319

2238

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.6

878

7305

A98

ICPC

Health maint/preventive medicine

1.4

8.6

2387

22744

M01AB55

ATC

diclofenac, combinations; oral

1.7

8.6

180

1100

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

8.5

354

2537

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

8.5

442

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

9.0

8.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.5

325

2294

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

8.5

344

2455

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.5

222

1436

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

20.1

8.5

KMAK

NOMESCO Finland

1.3

8.5

1021

8680

N01

ICPC

Headache

1.7

8.4

163

969

D84.1

ICD-10 Finland

Defects in the complement system

90.3

8.4

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

8.4

501

3842

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

8.3

102

518

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

8.3

181

1115

M36.8*D80.1

ICD-10 Finland

Systemic disorders of connective tissue in hypogammaglobulinaemia

+∞

8.3

D84.18

ICD-10 Finland

Other specified defect in the complement system

+∞

8.3

J06BA02

ATC

immunoglobulins, normal human, for intravascular adm.; systemic

+∞

8.3

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

+∞

8.3

0310A

ICD-9 Finland

Diseases due to other mycobacteria, Pulmonary

+∞

8.3

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.6

8.3

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.4

8.3

301

127

Kela drug reimbursment

Transplant complication

3.3

8.3

118

356

Kela drug reimbursment

Nintedanib and pirfenidone

6.2

8.3

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

8.3

354

H05AA02

ATC

teriparatide; parenteral

5.5

8.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

8.2

356

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

8.2

302

2116

Z94.2

ICD-10 Finland

Lung transplant status

14.5

8.2

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

8.2

171

1042

U02

ICPC

Urinary frequency/urgency

1.5

8.2

314

2220

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

8.2

278

L04

ICPC

Chest symptom/complaint

1.8

8.2

129

722

J32

ICD-10 Finland

Chronic sinusitis

7.5

8.1

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

7.5

8.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

8.1

169

1027

R01AD

ATC

Corticosteroids

3.6

8.1

L14

ICPC

Leg/thigh symptom/complaint

1.7

8.1

174

1070

R21

ICPC

Throat symptom/complaint

1.5

8.1

310

2187

SPAT1211

SPAT

Application of soft bandage

1.6

8.1

213

1380

Q32.0

ICD-10 Finland

Congenital tracheomalacia

33.4

8.1

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

8.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

8.1

1076

9248

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.1

8.1

132

G04CA02

ATC

tamsulosin; oral

1.3

8.0

555

4353

M01CB01

ATC

sodium aurothiomalate; parenteral

2.7

8.0

195

L02

ICPC

Back symptom/complaint

1.6

7.9

179

1116

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

4.0

7.9

RS221

NOMESCO Finland

3.3

7.9

112

SPAT1281

SPAT

Other administrative function

1.7

7.9

170

1043

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.4

7.9

107

D11

ICPC

Diarrhoea

1.6

7.9

186

1171

L16

ICPC

Ankle symptom/complaint

1.6

7.9

202

1303

M03BX02

ATC

tizanidine; oral

1.3

7.8

1273

11195

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

8.5

7.8

A07AA09

ATC

vancomycin; oral

3.2

7.8

119

A01

ICPC

Pain general/multiple sites

1.7

7.8

172

1065

D07AB08

ATC

desonide; topical

1.6

7.7

214

1406

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

7.7

180

46104

ICD-8 Finland

Acute sinusitis, Pansinuitis

45.1

7.7

R25

ICPC

Sputum/phlegm abnormal

15.0

7.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

7.7

396

J33.9

ICD-10 Finland

Nasal polyp, unspecified

4.2

7.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.7

239

1614

N05AH04

ATC

quetiapine; oral

1.5

7.7

276

1924

M31.3

ICD-10 Finland

Wegener granulomatosis

7.4

7.7

R07.0

ICD-10 Finland

Pain in throat

1.9

7.7

105

557

DC1AD

NOMESCO Finland

Temporalbone CT

3.6

7.6

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.6

7.6

214

B01AB05

ATC

enoxaparin; parenteral

1.3

7.6

728

5978

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

7.6

109

589

B02.9

ICD-10 Finland

Zoster without complication

1.8

7.6

135

783

SPAT1104

SPAT

Monitoring of emergency patient

1.7

7.6

159

971

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

7.6

194

1250

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

7.6

510

3981

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

25.1

7.6

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

7.5

104

553

J01.4

ICD-10 Finland

Acute pansinusitis

6.2

7.5

XJC10

NOMESCO Finland

Oesophageal pH monitoring

5.4

7.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

7.5

278

1947

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.1

7.5

123

C08DB01

ATC

diltiazem; oral

1.7

7.5

146

875

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

3.2

7.4

118

D80.6

ICD-10 Finland

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

80.3

7.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

7.4

154

940

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.0

7.4

N06AB10

ATC

escitalopram; oral

1.4

7.4

331

2408

XKD00

NOMESCO Finland

Uroflowmetry

1.4

7.4

388

2907

R01BA01

ATC

phenylpropanolamine; oral

1.8

7.3

116

647

R01AX03

ATC

ipratropium bromide; nasal

2.4

7.3

243

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.4

7.3

251

WX872

NOMESCO Finland

Intensive care

1.8

7.3

116

648

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

7.3

174

1099

L01AA01

ATC

cyclophosphamide; systemic

4.7

7.3

WX320

NOMESCO Finland

Spinalanesthesy

1.3

7.3

529

4174

RF310

NOMESCO Finland

8.4

7.3

A31.80

ICD-10 Finland

Oral infection caused by Mycobacterium intracellulare

+∞

7.3

Q33.4

ICD-10 Finland

Congenital bronchiectasis

+∞

7.3

1370A

ICD-9 Finland

Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,TUBERKULOOSIARPI]

+∞

7.3

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

7.3

245

SPAT1060

SPAT

Administration of oxygen

6.8

7.3

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

7.3

518

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.3

316

2289

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

7.2

142

851

SPAT1252

SPAT

Overall medication plan or its review

1.6

7.2

173

1094

5AH02

NOMESCO Finland

15.8

7.2

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.8

7.2

J01CA02

ATC

pivampicillin; oral

2.3

7.1

291

WX882

NOMESCO Finland

High dependency care

2.2

7.1

313

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

7.1

325

R05DB05

ATC

pentoxyverine; oral, rectal

2.0

7.1

436

DMB10

NOMESCO Finland

Radical maxillary antrotomy

5.0

7.1

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.0

7.0

123

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

7.0

558

4459

GX2D5

NOMESCO Finland

Sleep oximetry

10.0

7.0

WX721

NOMESCO Finland

Oxygen concentrator therapy

10.0

7.0

01102

ICD-8 Finland

Pulmonary tuberculosis, Non cavernosa

7.0

D01

ICPC

Abdominal pain/cramps general

1.5

7.0

204

1356

N04BC05

ATC

pramipexole; oral

1.6

7.0

169

1076

S51.8

ICD-10 Finland

Open wound of other parts of forearm

4.0

7.0

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

6.9

249

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

6.9

154

955

Z01.2

ICD-10 Finland

Dental examination

1.3

6.9

802

6744

H26.3

ICD-10 Finland

Drug-induced cataract

5.5

6.9

A05

ICPC

Feeling ill

1.9

6.9

521

78329

ICD-8 Finland

Symptoms referable to respiratory system, Dyspnoea alia sive NUD

5.8

6.9

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

6.9

101

551

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.9

218

1476

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

7.5

6.9

Y3498

ICD-8 Finland

Follow-up examination of illness, accident or surgery, Other illnesses, accidents or surgeries

13.8

6.9

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

13.8

6.9

F1246

NOMESCO Finland

13.8

6.9

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.6

6.9

C01AA05

ATC

digoxin; systemic

1.5

6.9

203

1354

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.4

6.9

222

E000002

ATC

1.5

6.8

204

1363

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.0

6.8

389

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

6.8

106

589

XF404

NOMESCO Finland

Ambulatory ECG

1.5

6.8

223

1522

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

6.8

112

637

L01XE31

ATC

[U] nintedanib; oral

8.3

6.8

55130

ICD-8 Finland

Other hernia of abdominal cavity without mention of obstruction, Diaphragmatic

6.7

6.8

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

6.8

161

1019

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

6.8

121

707

5826

FHL

Lobectomy or bilobectomy

10.9

6.8

S29

ICPC

Skin symptom/complaint other

1.4

6.8

381

2884

R43

ICPC

Respiratory, Other diagnostic procedure

5.0

6.8

N06AX16

ATC

venlafaxine; oral

1.5

6.8

221

1507

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.5

6.8

198

C05AA01

ATC

hydrocortisone; rectal, topical

1.7

6.8

124

729

R4190

NOMESCO Finland

Nutritional therapy

2.1

6.8

333

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

4.0

6.8

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.9

6.7

491

GD1CG

NOMESCO Finland

Extensive examination of lungs and pleura with high intensity magnet

16.7

6.7

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.4

6.7

218

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

6.7

243

1694

S01

ICPC

Pain/tenderness of skin

1.9

6.7

507

M05BA06

ATC

ibandronic acid; systemic

2.3

6.7

249

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

6.7

302

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

7.2

6.7

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

7.2

6.7

D07AC01

ATC

betamethasone; topical

1.3

6.7

737

6153

P06

ICPC

Sleep disturbance

1.6

6.7

169

1084

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.7

312

2286

XG420

NOMESCO Finland

Time-volume spirometry

22.6

6.7

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

6.7

121

708

G01AF04

ATC

miconazole; vaginal

1.9

6.7

513

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.7

356

2674

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

6.6

103

575

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

6.6

356

2677

R07

ICPC

Sneezing/nasal congestion

1.9

6.6

501

XJC00

NOMESCO Finland

Oesophageal manometry

6.4

6.6

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

7.8

6.6

N05CF02

ATC

zolpidem; oral

1.4

6.6

345

2582

M02AA07

ATC

piroxicam; topical

1.3

6.6

874

7458

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.6

194

1296

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

6.6

276

1986

B01AC04

ATC

clopidogrel; oral

1.4

6.6

389

2971

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

6.5

451

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

6.5

468

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

6.8

6.5

J01MA06

ATC

norfloxacin; oral

1.4

6.5

311

2292

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

6.5

243

1709

A11

ICPC

Chest pain NOS

1.6

6.5

176

1150

50708

ICD-8 Finland

Hay fever, Alia definita

5.0

6.5

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

6.5

247

1742

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

6.5

191

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

6.4

105

596

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

6.4

171

1114

A31.89

ICD-10 Finland

Other mycobacterial infections

70.0

6.4

D83.8

ICD-10 Finland

Other common variable immunodeficiencies

70.0

6.4

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

6.4

507

4046

R05DA01

ATC

ethylmorphine; oral

1.6

6.4

177

1163

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

6.4

221

1527

S81.0

ICD-10 Finland

Open wound of knee

2.9

6.4

130

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.0

6.4

115

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

6.4

344

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

6.4

495

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.1

6.4

345

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

6.4

395

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

6.3

100

560

SPAT1097

SPAT

Recording of ECG

1.4

6.3

364

2767

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.4

6.3

216

L04AX05

ATC

pirfenidone; oral

6.0

6.3

R03DB04

ATC

theophylline and adrenergics; systemic

11.0

6.3

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

11.0

6.3

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

6.3

474

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

6.3

352

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

18.0

6.3

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.3

456

3596

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.3

6.3

N06AB03

ATC

fluoxetine; oral

1.5

6.2

240

1695

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

+∞

6.2

304

Kela drug reimbursment

Dornase alfa

+∞

6.2

49308

ICD-8 Finland

Asthma, Alia definita

+∞

6.2

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

6.2

GD1DG

NOMESCO Finland

Extremely extensive MRI examination of pleura with high field magnet

26.7

6.2

P01

ICPC

Feeling anxious/nervous/tense

1.7

6.2

117

694

N02AC04

ATC

dextropropoxyphene; oral

1.8

6.2

543

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.2

407

3160

RD211

NOMESCO Finland

1.9

6.2

498

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

5.0

6.2

J01CF05

ATC

flucloxacillin; systemic

2.0

6.2

398

A02BX02

ATC

sucralfate; oral

1.7

6.2

108

629

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

6.3

6.2

R03BA07

ATC

mometasone; inhalant

5.3

6.1

R06.4

ICD-10 Finland

Hyperventilation

3.0

6.1

107

I20.09

ICD-10 Finland

Unstable angina

1.6

6.1

140

879

SPAT1259

SPAT

Opinion on plain films

3.3

6.1

ZX114

NOMESCO Finland

Intramuscular

2.8

6.1

129

R2110

NOMESCO Finland

Giving the first information

1.7

6.1

128

784

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.1

878

7550

SPAT1312

SPAT

General health counselling

1.3

6.1

696

5827

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

6.1

224

1571

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

3.6

6.1

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

6.1

247

ZX100

NOMESCO Finland

Oral

2.7

6.1

143

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

6.1

494

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

6.0

380

-34

ICPC

Blood test

2.0

6.0

353

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.0

492

3940

AN1

Coronary angiography

1.4

6.0

286

2106

J01

ICD-10 Finland

Acute sinusitis

1.9

6.0

468

G04CA01

ATC

alfuzosin; oral

1.4

6.0

256

1846

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005719) IgG [Mass/volume] in Serum or Plasma

741

1670

5.56

321.06

4.2

2.8

10.6

g/l

0.11

709

1506

(3024139) IgG subclass 3 [Mass/volume] in Serum

267

150

19.43

307.65

1.4

1.3

0.4

g/l

0.41

200

104

(4062490)

268

152

19.25

307.65

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

243

29.28

307.65

7.1

2.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

478

158

35.76

307.65

6.0

3.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

818

789

13.85

307.65

1.9

1.1

233.1

174.3

u/ml

0.66

775

708

(4010399)

636

1188

6.52

307.65

1.7

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

365

129.62

307.65

1.7

1.1

1.2

0.0

u/ml

—

266

(3028192) IgG subclass 2 [Mass/volume] in Serum

267

150

19.43

307.65

1.4

1.3

2.9

2.8

g/l

0.16

197

105

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

744

742

12.98

307.65

4.3

2.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

267

150

19.43

307.65

1.4

1.3

7.1

g/l

0.01

198

106

(3042631) Mycobacterium sp identified in Specimen

358

284

14.17

307.65

6.2

2.2

—

(3023419) Bacteria identified in Sputum by Culture

869

159

76.36

307.65

4.8

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

615

1337

5.52

274.82

2.1

1.9

1.1

1.5

g/l

3.75

580

1189

(3024980) IgG subclass 4 [Mass/volume] in Serum

289

268

11.82

273.10

1.5

0.7

0.9

g/l

1.45

219

199

(4015189)

158

41.63

261.43

4.6

1.4

—

(3013115) Eosinophils [#/volume] in Blood

2188

12104

3.94

256.38

10.3

5.8

0.2

e9/l

7.46

2025

10359

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

360

486

8.28

256.14

1.8

1.4

—

(3001604) Monocytes [#/volume] in Blood

2143

11710

3.87

255.55

9.7

5.5

0.7

0.6

e9/l

7.39

1975

9878

(3006315) Basophils [#/volume] in Blood

2149

11770

3.87

255.21

9.8

5.6

0.0

e9/l

4.64

1979

9939

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

130

113.17

254.24

1.5

1.1

—

(3000494) Fungus identified in Specimen by Culture

867

2644

4.20

252.33

2.5

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

2160

12008

3.81

247.41

9.8

5.7

1.9

e9/l

0.18

2008

10315

(3022096) Basophils/100 leukocytes in Blood

1995

10735

3.53

236.32

10.3

5.9

0.7

0.28

1933

9869

(3019069) Monocytes/100 leukocytes in Blood

2033

11089

3.56

235.07

10.6

6.2

8.9

0.21

1969

10220

(3006504) Eosinophils/100 leukocytes in Blood

2024

11039

3.53

233.41

10.3

5.8

2.9

2.8

1.29

1958

10138

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

256

253

10.96

231.10

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

2023

11141

3.48

227.19

10.1

5.7

58.9

57.6

4.89

1958

10256

(3002030) Lymphocytes/100 leukocytes in Blood

2043

11324

3.49

226.88

10.4

6.0

25.8

27.3

7.15

1973

10371

(42870588) Differential panel, method unspecified - Blood

1660

8247

3.25

219.32

9.1

5.6

—

(3000492) Spirometry study

546

1346

4.73

207.03

2.1

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2245

13986

3.37

188.91

12.4

9.0

4.6

4.1

e9/l

17.12

2077

12037

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1036

4214

3.22

186.83

2.8

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

254

342

8.02

179.90

1.7

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

275

8.55

165.62

1.7

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

172

155

11.71

164.65

1.6

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

767

2870

3.24

155.66

2.5

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

759

2856

3.21

152.24

2.6

1.7

—

(3011412) CD3 cells [#/volume] in Blood

175

198

9.32

142.32

1.9

2.0

1.2

1.1

e9/l

1.04

102

118

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

214

314

7.26

140.01

1.6

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

29.05

138.99

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

274

522

5.67

138.32

2.0

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

200

279

7.61

136.86

1.6

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

139

123

11.80

134.44

1.8

1.9

0.3

0.2

e9/l

1.29

113

105

(3007164) IgA [Mass/volume] in Serum or Plasma

914

4053

2.80

134.25

2.0

1.5

2.6

2.5

g/l

0.28

664

2292

(3023368) Bacteria identified in Blood by Culture

1355

7304

2.55

133.63

6.1

4.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

140

129

11.33

131.82

1.8

1.9

589.0

562.1

e6/l

0.11

114

106

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

261

505

5.56

129.39

2.0

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

43.87

129.23

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

247

468

5.66

125.20

1.7

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

247

468

5.66

125.20

1.7

1.2

—

(3042936) Bacteria identified in Isolate by Culture

805

3476

2.79

123.02

2.4

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

362

984

4.04

117.81

1.7

1.6

23.9

24.2

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

100

16.38

117.63

1.4

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

139

150

9.67

116.98

1.7

2.1

13.8

15.0

0.31

(1175426) CD3 cells/100 lymphocytes in Blood

140

154

9.48

116.13

1.7

2.1

71.5

70.3

0.25

134

141

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

213

387

5.85

112.72

2.0

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2454

18406

2.79

106.70

7.5

4.0

17.5

13.6

mm/h

22.32

2313

16738

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

130

151

8.95

103.34

1.9

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

642

2725

2.72

99.13

2.5

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

14.24

98.27

1.7

2.1

29.1

28.6

0.07

(3006245) CD3-CD19+ cells/100 cells in Blood

13.82

96.58

1.7

2.1

12.5

11.1

0.21

(21494815) CD4 cells/100 lymphocytes in Specimen

123

162

7.87

88.16

1.8

2.1

41.1

43.5

0.16

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

277

763

3.90

87.75

1.8

1.5

500.9

262.6

titre

0.58

(3037522) Nuclear Ab [Titer] in Serum

631

2806

2.58

87.66

1.3

573.3

566.4

titre

0.03

132

645

(3024891) Influenza virus A+B Ag [Presence] in Specimen

206

466

4.67

84.61

1.4

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

159

305

5.45

79.08

1.9

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

9.95

78.91

3.6

2.2

609.2

1503.8

u/ml

2.40

(40760892) CBC W Ordered Manual Differential panel - Blood

885

4771

2.21

78.17

7.2

4.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

143

252

5.91

77.86

1.1

1.5

1.6

g/l

1.67

134

228

(3000060) B lymphocytes [#/volume] in Blood

15.20

76.03

1.6

2.1

211.9

238.1

e6/l

0.14

(3002179) Metamyelocytes/100 leukocytes in Blood

458

1856

2.73

75.92

5.6

4.0

0.6

0.14

107

444

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

230

623

3.91

74.36

2.0

1.4

24.9

17.5

iu/ml

—

(3021589) Normoblasts [#/volume] in Blood

1565

10583

1.99

73.60

15.1

9.8

0.0

e9/l

1.19

1340

8573

(3017181) Myelocytes/100 leukocytes in Blood

481

2040

2.62

72.60

5.8

4.1

0.6

0.9

1.45

139

633

(3019060) Gas panel - Arterial blood

408

1602

2.79

71.66

4.6

4.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

606

2883

2.38

71.31

6.9

6.7

5.3

5.0

kpa

5.20

567

2750

(3027801) Oxygen [Partial pressure] in Arterial blood

605

2881

2.38

71.01

6.9

6.7

10.8

12.6

kpa

18.04

565

2748

(3021440) Promyelocytes/100 leukocytes in Blood

462

1941

2.63

70.98

5.9

4.2

0.1

0.15

130

583

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

116

184

6.52

70.15

2.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

116

184

6.52

70.15

2.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

116

184

6.52

70.15

2.0

1.5

—

(3025159) Blasts/100 leukocytes in Blood

438

1810

2.66

69.49

6.0

4.2

0.1

0.3

0.82

111

485

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1849

13407

1.98

69.26

7.1

6.2

11.1

12.2

umol/l

3.01

1781

12681

(3003396) Base excess in Arterial blood by calculation

598

2876

2.35

68.37

7.0

6.7

2.0

0.9

mmol/l

7.60

480

2230

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

134

7.53

67.93

2.0

1.9

732.4

635.7

e6/l

0.63

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1731

12324

1.95

67.82

7.5

5.8

1.2

mmol/l

0.40

1574

11017

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

208

563

3.89

67.22

2.4

1.9

11.1

12.5

mg/l

1.20

197

508

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

122.90

67.15

1.9

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

525

2420

2.42

65.89

1.5

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1855

13607

1.94

65.44

8.1

6.5

1.2

mmol/l

0.07

1559

11370

(40758558) Short blood count panel - Blood

1021

6148

2.00

64.91

9.0

6.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2431

19716

2.20

63.38

10.7

7.5

80.7

80.8

u/l

0.03

2339

18379

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

249

5.32

62.59

2.0

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

119

218

5.64

62.13

2.0

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

169

416

4.24

62.12

1.4

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

853

4889

2.04

61.76

2.2

1.7

1.2

1.5

mg/l

1.46

665

3785

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

122

232

5.44

61.17

2.0

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

208

610

3.59

59.69

1.5

0.2

g/l

0.36

197

574

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

211

632

3.51

58.62

1.5

1.2

g/l

0.21

202

595

(44790047)

118

229

5.32

57.84

1.8

1.4

—

(44806118)

118

229

5.32

57.84

1.8

1.4

—

(44790049)

118

229

5.32

57.84

1.8

1.4

—

(44790048)

118

229

5.32

57.84

1.8

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1257

8379

1.86

56.93

4.0

3.0

1646.8

1685.9

ng/l

0.11

1105

7250

(3009343) pH of Capillary blood

364

1515

2.60

56.33

6.5

3.4

7.4

0.58

175

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

323

1269

2.73

56.09

7.6

8.8

25.3

24.1

mmol/l

6.98

293

1186

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

366

1536

2.57

55.65

6.5

3.4

5.3

5.1

kpa

4.01

345

1394

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

161

419

4.00

54.85

1.2

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

417

1894

2.39

53.35

2.0

1.6

—

(3016502) Oxygen saturation in Arterial blood

522

2609

2.21

53.28

7.2

7.0

94.4

95.9

6.22

498

2514

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

348

1459

2.57

52.91

6.3

3.4

2.2

1.7

mmol/l

1.95

285

1043

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1634

11974

1.80

52.72

3.3

2.4

—

(3032080) INR in Blood by Coagulation assay

1536

11093

1.78

51.69

10.5

10.1

1.3

inr

0.64

427

3021

(3022313) Gas panel - Capillary blood

286

1126

2.70

49.26

6.6

3.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

372

1662

2.41

49.18

2.3

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

711

4102

1.96

48.84

2.5

10.9

12.6

umol/l

8.48

659

3771

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

110

6.97

48.79

2.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

110

6.97

48.79

2.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

110

6.97

48.79

2.3

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

110

6.97

48.79

2.3

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

248

912

2.87

48.63

2.0

1.8

38.7

39.0

u/l

0.09

220

777

(3028433) Virus identified in Specimen by Culture

8.60

46.87

1.3

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

159

458

3.61

46.77

1.5

1.2

136.7

445.0

titre

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1034

6818

1.79

46.05

2.6

2.2

3.2

3.0

mg/l

1.38

888

5756

(3004789) Transferrin [Mass/volume] in Serum or Plasma

663

3811

1.95

45.66

2.4

2.5

2.2

2.3

g/l

0.71

612

3512

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

5.86

45.53

1.9

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

649

3708

1.96

45.48

1.3

1.2

47.9

37.9

iu/ml

0.64

235

1129

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

18.21

44.71

3.7

2.3

1.0

1.5

mg/l

0.48

(3024561) Albumin [Mass/volume] in Serum or Plasma

1559

11604

1.71

44.57

5.2

4.6

33.8

35.1

g/l

15.67

1439

10705

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

153

445

3.57

44.34

4.3

3.7

58.2

57.6

0.17

153

445

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

135

365

3.83

43.55

1.7

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2102

17082

1.76

42.73

6.3

4.9

127.4

2563.2

e6/l

4.46

260

(3018418) pH of Serum or Plasma

1159

8029

1.72

42.56

4.8

4.0

7.4

0.45

249

1499

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

621

3582

1.92

41.92

2.6

19.7

22.4

5.15

530

3019

(3037467) Urinalysis macro (dipstick) panel - Urine

2130

17459

1.75

41.03

6.1

4.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

126

5.91

40.55

2.0

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1400

10293

1.67

40.51

5.0

3.7

37.2

103.4

ng/l

0.95

1074

7707

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

7.05

40.28

2.2

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

210

4.64

39.99

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

224

4.49

39.58

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

127

5.78

39.11

2.0

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1344

9847

1.66

38.90

3.3

2.7

141.5

148.7

ug/l

0.33

1228

8917

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2714

24220

2.20

37.56

31.5

15.0

25.7

25.8

mg/l

0.08

2476

19262

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

8.28

37.23

2.1

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

6.78

36.96

2.2

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

6.78

36.96

2.2

1.6

—

(36304419) Bacteria [Presence] in Urine

1016

7021

1.67

36.21

4.1

3.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

595

3532

1.85

36.18

1.3

1.2

29.0

15.2

u/ml

1.91

201

1249

(3012095) Magnesium [Moles/volume] in Serum or Plasma

675

4170

1.80

35.99

4.3

3.1

0.8

mmol/l

0.21

622

3853

(3030467) Casts [#/volume] in Urine by Automated count

1043

7285

1.66

35.51

4.2

3.2

0.3

0.5

e6/l

1.39

814

5503

(3020630) Protein [Mass/volume] in Serum or Plasma

441

2394

1.99

35.05

2.7

2.6

65.6

66.1

g/l

0.73

394

2148

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

443

2410

1.98

34.99

3.6

2.9

211.6

221.2

ng/l

0.16

406

2199

(3000850) Epithelial cells [#/volume] in Urine

843

5590

1.71

34.84

3.2

2.6

4.8

5.4

e6/l

0.67

746

4887

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.99

34.78

1.7

2.6

3357.6

39905.2

u/ml

0.47

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

189

4.54

34.61

2.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

128

5.41

34.48

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

186

704

2.75

34.38

2.0

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

389

2034

2.05

34.30

2.5

2.1

318.9

387.5

nmol/l

9.83

360

1835

(3026782) Osmolality of Urine

796

5223

1.71

34.07

3.4

2.8

523.5

545.9

mosm/kgh2o

2.64

687

4425

(3010726) Horse dander IgE Ab [Units/volume] in Serum

116

5.62

33.80

1.1

1.0

1.4

3.8

u/ml

0.52

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1397

10575

1.60

33.79

2.9

2.2

82.5

79.9

nmol/l

2.47

1251

9233

(3013826) Glucose [Moles/volume] in Serum or Plasma

1877

15273

1.61

33.13

6.3

4.5

6.6

6.8

mmol/l

7.28

1793

14315

(3015235) Bicarbonate [Moles/volume] in Capillary blood

160

571

2.90

33.00

4.4

3.0

25.1

24.6

mmol/l

0.78

142

482

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

62.40

32.07

1.2

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

160

4.72

32.02

1.1

0.4

0.7

u/ml

0.44

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

165

617

2.77

31.20

1.6

19.6

1.4

iu/ml

0.45

127

(3014111) Lactate [Moles/volume] in Serum or Plasma

416

2309

1.93

30.74

6.7

6.1

1.4

mmol/l

0.16

390

2230

(3002582) Erythrocytes [#/volume] in Urine

1096

7963

1.59

30.67

4.3

3.3

73.0

88.8

e6/l

0.34

860

6105

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

46.77

30.60

1.2

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

434

2454

1.90

30.29

7.5

7.2

121.0

119.1

g/l

1.21

413

2371

(3000991) Gas panel - Venous blood

397

2180

1.95

30.26

7.7

7.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

5.69

30.05

1.1

1.0

4.4

3.4

u/ml

0.09

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

770

5162

1.66

29.75

5.6

3.7

269.9

579.0

ng/l

0.87

641

4331

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

526

3175

1.80

29.72

4.6

4.3

234.0

250.8

u/l

2.05

498

2971

(3052851) Hemolysis interference index of Serum or Plasma

187

764

2.54

29.63

3.7

3.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

148

540

2.83

29.30

5.8

2.9

7.9

8.2

kpa

1.82

137

492

(3003888) Timothy IgE Ab [Units/volume] in Serum

140

4.80

29.23

1.0

1.1

2.1

5.6

u/ml

1.33

(3023430) Cat dander IgE Ab [Units/volume] in Serum

5.78

28.97

1.1

1.0

1.6

2.5

u/ml

0.26

(3004588) Protein electrophoresis panel - Serum or Plasma

371

2019

1.95

28.97

2.4

2.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1080

7912

1.57

28.67

2.7

2.5

60.6

58.5

u/l

0.35

995

7215

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

277

1364

2.13

28.46

9.8

9.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

299

1520

2.07

28.24

1.9

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

190

802

2.46

28.08

1.1

1.2

0.7

1.2

u/ml

0.35

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

447

2.97

28.06

5.9

4.9

398.4

826.9

iu/ml

0.58

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

219

991

2.30

27.68

7.8

3.6

25.4

24.7

mmol/l

2.67

202

901

(3021901) Oxygen saturation in Capillary blood

123

419

3.02

27.57

3.7

2.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1011

7358

1.56

27.31

3.7

3.1

31.6

39.5

u/l

2.03

955

6958

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

241

1143

2.20

27.20

3.2

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

529

3278

1.74

27.08

2.8

2.5

1.8

0.28

448

2867

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

11.84

26.50

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.71

26.47

1.8

2.0

—

(3018095) Leukocytes [#/volume] in Urine

1209

9200

1.52

26.42

5.0

3.8

69.9

124.7

e6/l

2.68

913

6543

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

426

2506

1.81

25.97

2.6

2.2

0.2

g/l

0.65

403

2331

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

233

1111

2.19

25.93

2.4

1.9

1.3

3.1

ug/l

2.12

201

957

(3003458) Phosphate [Moles/volume] in Serum or Plasma

541

3425

1.71

25.49

6.7

5.6

1.0

mmol/l

0.08

488

3157

(3025018) Bordetella pertussis Ab [Titer] in Serum

5.59

25.38

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

137

4.52

25.24

1.0

1.1

0.4

2.1

u/ml

0.95

(3006184) Hemoglobin [Mass/volume] in Capillary blood

139

532

2.69

25.13

2.3

2.2

125.0

126.1

g/l

0.16

385

(3033658) Prothrombin time (PT) actual/Normal

887

6381

1.55

24.71

5.5

3.8

85.9

86.6

0.39

864

6230

(3021447) Carbon dioxide [Partial pressure] in Venous blood

415

2489

1.77

23.57

3.8

3.6

6.1

5.8

kpa

5.88

399

2428

(40768797) Stomach Pathology biopsy report

526

3393

1.67

22.87

1.3

1.2

—

(1616796) Gas panel - Central venous blood

132

519

2.61

22.63

5.5

3.5

—

(3002032) Base excess in Venous blood by calculation

410

2483

1.75

22.45

3.9

3.6

2.8

1.8

mmol/l

4.95

353

2003

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1431

11534

1.46

22.19

2.2

2.1

94.8

94.7

pmol/l

0.02

763

5761

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.78

21.95

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

167

3.89

21.78

1.2

278.8

133.3

titre

—

(3012501) Base excess in Blood by calculation

136

555

2.52

21.60

6.3

3.8

2.7

2.6

mmol/l

0.16

103

363

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

214

1063

2.09

21.39

2.8

1.7

—

(3026008) Bacteria identified in Urine by Culture

1123

8683

1.47

21.39

3.9

3.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

130

4.29

21.37

2.3

2.5

37.8

36.3

0.18

(3008152) Bicarbonate [Moles/volume] in Arterial blood

291

1620

1.88

20.98

7.4

6.5

25.6

24.3

mmol/l

5.86

266

1511

(3010421) pH of Blood

150

650

2.38

20.92

5.9

3.6

7.4

0.34

132

543

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

5.06

20.91

1.1

1.0

0.1

0.5

u/ml

0.49

(3023520) Reticulocytes [#/volume] in Blood

408

2522

1.71

20.67

3.1

2.6

68.3

67.7

e9/l

0.13

286

1907

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

232

1202

2.01

20.67

3.8

4.1

25.2

24.0

mmol/l

4.96

211

1081

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

101

4.71

20.55

1.1

10.8

13.8

iu/ml

—

(3048689) Calprotectin [Mass/mass] in Stool

400

2473

1.71

20.23

2.2

2.0

255.5

143.0

ug/g

1.12

317

1885

(3026493) Urate [Moles/volume] in Serum or Plasma

879

6539

1.49

20.08

3.3

2.8

5382.9

6271.4

umol/l

0.21

736

5528

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.07

19.38

2.0

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.26

19.38

2.1

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1176

9310

1.43

19.15

3.2

3.4

2.3

2.4

mmol/l

1.12

991

7931

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.69

19.15

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

143

637

2.31

18.74

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

147

668

2.26

18.38

1.8

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

352

2.75

18.34

3.7

2.9

1125.8

2055.2

u/ml

0.42

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

174

848

2.12

18.28

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

190

958

2.05

18.24

2.7

3.6

38.7

51.6

mg/l

0.70

146

799

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

652

4655

1.51

17.89

1.3

1.2

1.5

1.7

u/ml

0.17

152

1166

(3020779) Urea [Moles/volume] in Serum or Plasma

373

2336

1.68

17.88

7.8

7.0

10.1

10.7

mmol/l

1.03

350

2219

(3021960) Folate [Moles/volume] in Serum or Plasma

888

6752

1.45

17.68

1.7

1.6

20.3

21.0

nmol/l

0.55

770

5637

(3034860) Kappa light chains.free [Mass/volume] in Serum

189

962

2.03

17.68

2.7

3.5

70.8

60.4

mg/l

0.16

145

801

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1075

1.97

17.63

2.6

3.2

3.1

g/l

0.72

168

822

(3018677) aPTT in Platelet poor plasma by Coagulation assay

586

4102

1.53

17.61

3.5

2.0

30.1

29.9

0.17

566

3963

(3035350) Ketones [Presence] in Urine by Test strip

1461

12133

1.40

17.57

4.6

3.9

0.0

estimate

0.00

347

2192

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1037

8135

1.42

17.30

2.5

2.1

181.2

201.7

u/l

0.29

958

7567

(40757373) Influenza virus identified in Isolate

5.66

17.26

1.7

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1155

1.93

17.23

2.6

2.5

3.8

3.7

g/l

0.15

167

804

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1156

1.93

17.18

2.6

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1157

1.92

17.14

2.6

2.5

7.6

7.4

g/l

1.16

171

839

(3021601) Nitrite [Presence] in Urine by Test strip

1461

12173

1.39

17.02

6.2

5.3

0.0

estimate

0.00

356

2204

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

169

839

2.07

16.92

2.9

2.4

0.0

g/l

0.18

159

757

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

593

4197

1.51

16.85

3.7

3.0

2.5

e6/l

0.01

300

2309

(3009261) Glucose [Presence] in Urine by Test strip

1474

12326

1.38

16.66

4.7

4.0

0.0

estimate

1.08

351

2160

(3014576) Chloride [Moles/volume] in Serum or Plasma

491

3343

1.56

16.65

7.3

6.1

103.4

104.3

mmol/l

4.13

479

3268

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

346

2165

1.68

16.59

3.8

3.7

87.3

90.7

ng/l

0.32

283

1824

(3047181) Lactate [Moles/volume] in Blood

158

771

2.11

16.56

6.6

6.2

1.2

1.3

mmol/l

1.17

136

686

(3003434) Protein [Mass/volume] in Pleural fluid

389

2.57

16.54

1.6

1.4

32.9

32.2

g/l

0.26

351

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

133

609

2.24

16.35

1.2

20.7

50.6

u/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

181

933

2.00

16.35

2.8

3.5

4.3

1.7

ratio

0.59

(3014007) Fractional oxyhemoglobin in Arterial blood

280

1661

1.76

16.29

8.9

7.9

92.8

94.2

2.61

280

1656

(3019309) Folate [Moles/volume] in Red Blood Cells

757

5675

1.45

15.97

1.9

1.8

1173.7

1173.1

nmol/l

0.01

568

4202

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

623

4504

1.48

15.85

3.5

2.8

0.9

1.2

e6/l

3.07

332

2594

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1689

14509

1.37

15.80

3.8

3.1

53.7

53.2

u/l

0.06

1546

13173

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

182

955

1.96

15.63

6.4

3.0

0.3

u/ml

0.12

114

565

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

110

475

2.37

15.52

1.2

24.1

4.7

u/ml

0.65

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

154

763

2.07

15.51

3.0

2.5

0.0

g/l

0.00

145

699

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

156

779

2.06

15.39

2.9

2.5

0.0

g/l

0.00

146

702

(3017732) Neutrophils [#/volume] in Blood

271

1619

1.74

15.37

3.1

3.3

4.6

4.1

e9/l

1.64

208

1155

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

1083

1.90

15.33

2.7

2.6

10.3

g/l

0.05

171

891

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

184

980

1.93

15.13

2.8

2.5

0.7

1.0

g/l

0.77

163

819

(40768804) Tissue Pathology biopsy report

1237

10189

1.36

14.72

2.4

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2072

18497

1.38

14.66

4.4

4.0

15.1

15.0

pmol/l

1.38

1859

16412

(3002385) Erythrocyte distribution width [Ratio]

2151

19323

1.39

14.64

32.5

18.8

14.1

13.8

17.06

2127

18832

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

247

2.84

14.28

1.6

1.3

464.7

337.5

u/l

0.63

234

(40760888) Immunoglobulin light chains.free panel - Serum

144

720

2.05

14.17

2.6

3.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

352

2.52

14.16

1.4

2145.0

2098.1

e6/l

0.03

250

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

200

3.04

14.10

1.4

1.3

19.9

12.2

u/l

0.61

187

(3024354) Oxygen [Partial pressure] in Venous blood

325

2095

1.62

13.78

3.4

3.0

4.6

4.5

kpa

0.48

310

2041

(3028308) Erythrocytes [#/volume] in Pleural fluid

322

2.56

13.69

1.4

53757.7

91803.4

e6/l

0.46

188

(40767503) Oxygen content in Capillary blood by calculation

113

522

2.21

13.64

3.5

2.2

15.8

0.03

242

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

168

901

1.92

13.54

2.8

2.3

36.6

37.6

g/l

1.37

150

749

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

110

506

2.22

13.42

1.4

1.6

—

(3012441) Differential panel - Pleural fluid

296

2.61

13.39

1.6

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

392

2658

1.55

13.36

1.4

—

(3045788) Cell count panel - Pleural fluid

275

2.66

13.20

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.95

13.10

1.7

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

118

574

2.10

12.53

1.2

13.9

5.6

u/ml

0.51

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

117

568

2.10

12.49

1.2

4.5

3.4

u/ml

0.20

(3035880) pH of Pleural fluid

154

3.15

12.07

1.5

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2710

25653

1.55

11.90

30.7

18.1

139.2

139.7

mmol/l

13.18

2664

24930

(40761511) CBC panel - Blood by Automated count

2644

24906

1.50

11.80

24.2

14.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.71

11.47

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

395

2768

1.49

11.45

2.6

2.7

9.1

9.8

umol/l

0.22

349

2415

(3026389) Candida sp identified in Specimen by Organism specific culture

311

2.41

11.18

1.5

1.4

—

(3022145) Colonoscopy Study observation

387

2714

1.49

11.17

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2710

25714

1.53

11.09

31.0

18.2

4.0

mmol/l

1.32

2662

24956

(36660697) Celiac disease serology panel - Serum

261

1681

1.60

11.07

1.2

—

(44813793)

3.60

10.90

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

4.92

10.73

5.0

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

216

1354

1.64

10.23

1.6

1.7

1.6

1.5

g/l

0.86

184

1148

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

415

2.15

10.18

1.2

33.0

45.3

u/ml

0.39

(3000570) Elastase.pancreatic [Mass/mass] in Stool

141

786

1.83

10.14

1.3

1.4

295.0

272.1

ug/g

0.71

460

(3003327) Ova and parasites identified in Stool by Light microscopy

119

628

1.93

10.13

1.9

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

329

2290

1.49

9.82

4.7

3.8

1.2

mmol/l

2.14

297

1977

(3017143) Hepatitis C virus Ab [Presence] in Serum

294

2005

1.52

9.68

1.5

—

(3025941) Bacteria identified in Stool by Culture

197

1227

1.65

9.57

1.4

1.3

—

(3019225) pH of Specimen

405

2949

1.43

9.55

5.3

4.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

259

2.42

9.54

1.3

1.1

55.1

62.4

u/l

0.72

177

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2449

22953

1.36

9.45

24.3

14.7

75.5

74.3

ml/min/173m2

2.02

2165

18912

(3004616) Nuclear Ab [Presence] in Serum

286

2.34

9.37

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

157

2.83

9.27

1.7

1.5

8.4

7.2

u/l

0.14

(40768806) Pleura Pathology biopsy report

300

2.30

9.27

1.7

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.95

9.12

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.95

9.12

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.95

9.12

1.4

1.1

—

(40768443) Skin Pathology biopsy report

183

1135

1.65

9.05

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

347

2482

1.45

8.99

3.1

2.3

6.5

7.4

ug/l

0.48

281

2129

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2387

22334

1.33

8.96

5.5

4.8

2.0

2.1

mu/l

0.72

2164

19932

(3009542) Hematocrit [Volume Fraction] of Blood

2273

21128

1.31

8.91

29.8

16.7

39.0

38.6

0.88

1399

13439

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

3.47

8.91

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

769

6257

1.31

8.88

4.6

3.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

380

2773

1.42

8.83

4.4

3.5

—

(3013512) EKG study

974

8183

1.28

8.77

4.9

4.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

117

647

1.84

8.68

8.0

2.3

88.7

89.4

0.14

109

613

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

109

590

1.88

8.65

1.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

808

6658

1.29

8.41

5.4

4.4

0.0

estimate

0.69

341

2085

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

413

2.04

8.41

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

489

1.95

8.40

1.4

60.7

62.2

mmol/l

0.13

399

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

320

2285

1.45

8.36

2.4

29.5

40.9

u/l

4.19

270

1944

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2698

25804

1.43

8.27

16.1

10.9

24.1

24.9

u/l

1.31

2622

24620

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

660

5306

1.31

8.24

3.2

3.1

2.5

mmol/l

3.98

555

4662

(3004809) Band form neutrophils/100 leukocytes in Blood

471

1.94

7.93

3.4

3.9

1.3

1.4

0.08

355

(3044889) 12 lead EKG panel

1934

17728

1.25

7.86

5.2

4.1

—

(3013637) Mi-2 Ab [Presence] in Serum

4.06

7.80

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.06

7.80

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.06

7.80

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.06

7.80

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

18.39

7.60

1.0

0.2

g/l

—

(3020891) Body temperature

168

1068

1.61

7.57

4.9

4.1

—

(3039000) Anion gap in Blood

101

561

1.83

7.44

7.8

7.1

11.2

mmol/l

0.02

502

(3018572) Chloride [Moles/volume] in Blood

101

561

1.83

7.44

7.8

7.1

104.2

105.2

mmol/l

0.94

502

(3026250) Tacrolimus [Mass/volume] in Blood

3.31

7.24

35.7

34.3

6.8

7.1

ug/l

0.30

(3010375) cycloSPORINE [Mass/volume] in Blood

105

2.97

7.23

24.7

22.1

107.2

116.7

ug/l

0.28

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

334

2.06

7.18

8.4

6.5

12.0

12.1

mg/l

0.07

308

(3003740) Influenza virus B Ag [Presence] in Specimen

212

2.33

7.07

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

206

2.35

7.05

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

240

1679

1.47

6.99

3.3

3.2

124.6

127.2

g/l

1.06

235

1636

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

124

2.76

6.96

1.9

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.59

6.93

1.4

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

302

2208

1.41

6.92

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

280

2.13

6.83

3.9

3.2

—

(3051651) Icteric interference index of Serum or Plasma

149

2.57

6.77

3.8

3.3

—

(40761536) Microorganisms panel - Urine sediment

286

2081

1.41

6.74

5.5

4.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

496

3940

1.31

6.64

31.8

27.9

1.5

1.4

inr

0.65

570

(3002523) Influenza virus A Ag [Presence] in Specimen

212

2.28

6.63

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

2.72

6.60

1.9

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

496

1.82

6.53

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

118

2.73

6.43

1.5

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

170

1127

1.54

6.43

5.7

5.0

1.6

0.53

158

1060

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

370

1.94

6.40

2.3

2.1

34.2

25.9

mg/l

0.61

(3024928) Oxygen saturation in Venous blood

536

1.78

6.40

2.8

3.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

365

1.94

6.31

1.8

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

186

1265

1.50

6.25

3.0

2.6

1.3

1.1

1.77

186

1259

(3021879) Hepatitis B virus core Ab [Presence] in Serum

189

1292

1.49

6.20

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.13

6.16

1.1

1.3

147.9

543.2

ug/l

0.47

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

101

595

1.72

6.15

3.3

2.5

191.5

200.0

0.49

570

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

2.85

6.09

5.2

5.4

170.8

67.1

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

710

5957

1.25

6.08

4.5

3.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

356

1.93

6.07

1.8

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

357

1.93

6.02

1.8

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

357

1.93

6.02

1.8

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.88

5.98

1.4

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

166

1114

1.52

5.96

5.9

5.0

0.9

0.10

154

1051

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

211

1488

1.45

5.92

2.6

2.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

107

648

1.68

5.91

5.8

2.6

3.8

3.6

g/l

0.94

101

615

(3008757) Leukocyte morphology finding [Identifier] in Blood

298

2.00

5.85

3.2

4.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

2.67

5.82

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

192

1335

1.47

5.80

3.4

3.3

4.3

4.4

pmol/l

0.63

162

1143

(3036489) Thrombin time

131

841

1.58

5.74

3.9

2.0

22.2

21.5

0.36

119

752

(3010813) Leukocytes [#/volume] in Blood

2750

26618

1.37

5.73

40.8

22.8

7.5

6.7

e9/l

35.32

2688

25665

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

151

2.40

5.63

1.5

1.2

—

(3007461) Platelets [#/volume] in Blood

2748

26606

1.37

5.62

40.8

22.8

258.7

243.5

e9/l

22.33

2692

25757

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

359

1.89

5.61

1.8

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

109

673

1.64

5.60

3.6

3.1

0.8

nmol/l

0.01

513

(3024731) MCV [Entitic volume]

2748

26612

1.37

5.56

40.6

22.7

91.7

91.6

0.77

2715

26088

(3035941) MCH [Entitic mass]

2748

26614

1.36

5.54

40.5

22.7

30.2

30.4

8.21

2714

26091

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.82

5.53

1.4

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

2748

26615

1.36

5.53

40.7

22.8

4.4

e12/l

3.11

2691

25657

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

347

1.89

5.51

1.4

1.2

329.0

263.2

u/ml

0.74

201

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.07

5.49

1.9

1.6

0.3

0.4

ug/l

0.60

(3024522) Salmonella sp identified in Specimen by Organism specific culture

362

1.87

5.48

1.8

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

153

2.37

5.48

1.5

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

153

2.37

5.48

1.5

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

153

2.37

5.48

1.5

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

2748

26622

1.36

5.45

41.1

22.9

130.8

133.1

g/l

12.93

2713

26109

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.48

5.45

1.7

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

137

902

1.54

5.40

2.9

2.1

336.5

771.9

ug/l

1.13

127

852

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1047

9238

1.20

5.38

5.3

4.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

372

1.85

5.36

1.4

1.2

—

(3000012) Reticulocyte production index

161

2.31

5.35

1.6

—

(3037121) Protein [Mass/volume] in Urine

146

977

1.52

5.34

2.9

0.4

0.3

g/l

0.57

373

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

101

2.69

5.33

1.2

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

151

2.33

5.17

1.5

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

151

2.33

5.17

1.5

1.2

—

(3019977) pH of Arterial blood

127

2.46

5.12

2.0

2.5

7.4

0.70

(3044640) Blood type and Crossmatch panel - Blood

942

8261

1.20

5.11

2.8

2.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

13.36

5.08

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

259

1.99

5.03

3.4

2.8

—

(3035933) Granulocytes/100 leukocytes in Blood

3.41

5.02

2.0

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

280

1.95

5.02

1.3

1.2

1.7

4.3

u/ml

1.18

(3045142) Bone marrow Pathology biopsy report

344

1.85

5.01

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

124

815

1.54

4.95

4.8

3.7

3.9

mmol/l

0.10

119

758

(3035320) C reactive protein [Mass/volume] in Body fluid

161

2.25

4.91

4.3

2.3

—

(3003129) Base excess in Capillary blood by calculation

3.13

4.91

1.7

1.9

1.6

1.4

mmol/l

0.05

(3014271) Vancomycin [Susceptibility]

181

2.17

4.87

3.3

2.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

298

1.90

4.83

1.7

1.5

55.6

62.1

0.57

191

(3044927) Protein electrophoresis panel - Urine

334

1.84

4.83

1.1

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

5.01

4.77

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

300

1.88

4.74

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

508

1.67

4.73

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

190

1380

1.40

4.59

1.3

61.0

54.9

au/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

208

1536

1.38

4.55

2.4

2.5

10.2

25.1

au/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

270

1.90

4.50

1.2

3.4

4.6

u/ml

0.60

114

(3017354) Segmented neutrophils/100 leukocytes in Blood

292

1.86

4.47

3.2

3.7

61.4

56.6

1.05

177

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.28

4.46

1.3

1.0

—

(40768795) Lymph node Pathology biopsy report

258

1.91

4.40

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

101

653

1.57

4.37

5.2

3.8

1.7

1.6

mg/l

0.04

592

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.24

4.35

1.1

1.3

—

(21494434) Karyotype in Bone marrow

267

1.89

4.31

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

118

794

1.51

4.27

1.7

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.85

4.22

2.1

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

693

6006

1.20

4.15

1.7

11230428.9

27320236.7

pmol/l

0.65

561

4828

(3035637) Corticotropin [Mass/volume] in Plasma

257

1.88

4.12

1.4

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

732

6381

1.19

4.10

2.7

2.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.20

4.05

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

105

2.39

3.98

1.9

1.4

44.8

66.6

1.74

(3045716) Anion gap in Serum or Plasma

124

2.27

3.96

1.8

2.2

8.4

9.6

mmol/l

1.07

102

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

417

1.67

3.96

1.5

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.65

3.92

2.2

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

458

1.63

3.88

3.2

3.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

103

689

1.51

3.87

1.3

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

7.29

3.86

1.3

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.78

3.85

1.1

—

(4035726)

304

2432

1.28

3.84

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

436

1.64

3.84

1.4

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

242

1.87

3.83

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

3.07

3.80

2.0

1.7

—

(3017704) Immunofixation for Urine

173

2.04

3.79

1.5

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

8.77

3.77

1.4

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.54

3.76

1.1

88.2

122.8

ng/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

103

694

1.50

3.75

1.3

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

325

1.74

3.73

1.4

1.3

0.7

0.6

nmol/l

0.10

308

(1002224) Polysomnography panel

599

1.54

3.69

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1294

11888

1.15

3.69

4.3

4.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

103

699

1.49

3.63

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

366

1.68

3.62

1.5

1.4

108.4

124.2

u/ml

0.54

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.26

3.62

2.1

1.4

8.7

5.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.82

3.52

1.1

1.2

3.6

3.0

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.71

3.49

1.2

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

3.56

3.48

1.8

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

170

1276

1.35

3.43

1.2

74.7

139.7

iu/ml

2.57

448

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

103

708

1.47

3.43

1.5

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

334

1.69

3.42

1.1

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

282

1.75

3.39

1.5

1.3

—

nmol/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.73

3.34

1.1

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

681

1.47

3.30

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

226

1.83

3.28

1.5

28.7

27.8

0.06

149

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

191

1.90

3.24

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

294

1.71

3.23

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

103

2.24

3.22

1.1

1.0

—

(4268621)

185

1.90

3.19

2.3

2.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.38

3.18

1.1

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

125

2.09

3.08

1.2

1.1

79.6

79.8

u/l

0.00

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.01

3.05

1.4

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

126

2.07

3.02

1.2

1.1

31.3

26.4

u/l

0.14

(3023511) Choriogonadotropin [Units/volume] in Urine

107

2.16

2.96

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

623

1.46

2.94

1.8

1.6

8090.9

13079.2

e6/l

1.59

437

(4306422)

257

1.72

2.94

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.72

2.92

1.5

1.0

—

(3011648) Oxygen content in Venous blood

206

1.81

2.90

2.7

3.3

11.4

11.0

0.19

206

(3029075) Extractable nuclear Ab panel - Serum

2.59

2.87

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

308

1.63

2.76

1.8

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.01

2.72

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.01

2.72

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

526

1.48

2.71

2.5

2.7

31.6

36.8

umol/l

0.95

440

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.98

2.69

1.2

0.4

0.6

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

2.55

2.61

1.1

0.3

1.0

u/ml

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

142

1.91

2.55

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

142

1.91

2.55

1.4

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.61

2.53

1.4

—

(3008295) Osmolality of Serum or Plasma

271

1.63

2.47

1.5

1.4

268.4

277.3

mosm/kgh2o

1.45

201

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

295

1.60

2.45

1.3

192.8

299.9

pmol/l

1.63

222

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

250

2067

1.23

2.44

2.6

62.6

61.2

ml/min/173m2

0.24

104

891

(3036603) Volume of Urine

166

1.82

2.44

1.9

1.4

1790.0

1696.6

—

(3008898) HLA-B27 [Presence]

523

1.45

2.41

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

265

1.63

2.41

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

204

1.72

2.41

1.6

1.5

23.8

19.9

u/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

144

1118

1.30

2.39

1.4

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.34

2.39

1.2

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

2.39

1.0

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.34

2.39

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.34

2.39

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.26

2.37

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

362

3111

1.19

2.37

3.2

4.0

17.9

21.3

ug/l

0.13

313

2529

(3005011) Chlamydia sp Ab [Titer] in Serum

3.64

2.36

1.4

1.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.15

2.34

1.2

1.3

—

0.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

125

956

1.32

2.32

1.4

1.3

—

(3042733) HLA Ab [Presence] in Serum

2.46

2.27

5.0

4.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.90

2.25

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

302

1.57

2.25

1.9

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

2.24

0.0

2.4

—

2.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

2.10

2.12

6.4

7.1

27.1

24.8

mmol/l

1.52

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

220

1.64

2.12

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.37

2.12

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

197

1.68

2.12

1.4

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

102

1337

0.75

2.10

1.7

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.71

2.10

1.4

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.26

2.07

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

457

1.43

2.05

1.6

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

177

1.70

2.02

1.5

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

3.08

2.01

1.3

1.5

—

(40758292) HTLV I+II Ab panel - Serum

2.82

2.00

1.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

178

1.69

1.98

1.3

1.2

32.5

33.8

mmol/l

0.10

158

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

130

1025

1.28

1.97

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.55

1.94

2.8

4.3

—

(3046861) Legionella sp Ag [Presence] in Urine

4.55

1.94

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.57

1.92

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

1047

0.74

1.92

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

656

7178

0.89

1.91

3.0

3.2

—

(4027681)

1.93

1.90

1.3

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.65

1.86

1.2

1.3

80.4

75.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.53

1.83

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.17

1.82

1.0

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

177

1463

1.22

1.80

2.3

2.0

13.3

12.2

nmol/l

0.86

145

1271

(3024471) HLA-A [Type]

2.17

1.77

1.0

—

(3034426) Prothrombin time (PT)

2.17

1.77

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

288

1.50

1.77

3.7

6.3

7.8

7.4

mmol/l

0.28

234

(3000330) Specific gravity of Urine by Test strip

118

1478

0.79

1.75

5.1

3.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

541

1.36

1.74

1.8

1.6

—

(3023410) Appearance of Cerebral spinal fluid

209

1.59

1.73

1.2

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

717

6604

1.11

1.72

1.6

1.3

mmol/l

0.01

588

5475

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.85

1.71

1.0

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

194

1.60

1.71

1.4

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

333

1.45

1.68

1.4

1.3

14.1

11.7

u/l

0.37

268

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

180

1.62

1.66

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.16

1.66

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.16

1.66

1.0

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.25

1.63

2.2

1.0

14.4

16.5

umol/l

0.94

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.84

1.61

1.7

2.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

143

1.68

1.61

2.5

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.87

1.60

3.6

2.3

—

(3006653) Thiamine [Moles/volume] in Blood

113

1.78

1.60

1.2

142.9

138.1

nmol/l

0.20

113

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

394

3519

1.14

1.60

4.4

4.8

34.7

33.5

1.20

268

2234

(3050129) First trimester maternal screen panel - Serum or Plasma

142

0.42

1.51

1.3

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.60

1.51

1.3

2.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

1.71

1.50

1.2

1.1

—

(3002256) Pathology report gross observation

387

3468

1.13

1.50

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

186

1.56

1.48

2.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.45

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.73

1.43

1.0

—

(3024932) HLA-DR beta [Type]

2.04

1.43

1.1

—

(3014891) Appearance of Pleural fluid

2.31

1.43

2.4

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.73

1.42

2.2

2.8

105.7

96.0

0.58

102

(4094501)

642

1.29

1.39

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.61

1.36

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

224

1.48

1.33

1.2

1.3

—

(3049717) Cytology report of Urine Cyto stain

138

1153

1.21

1.33

2.7

2.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

342

1.38

1.32

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

168

1.55

1.31

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

351

1.37

1.31

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.10

1.30

2.1

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.36

1.29

1.1

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

633

1.27

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

125

1041

1.21

1.26

2.6

3.2

218.6

4405.5

u/ml

0.92

110

877

(3032773) Endomysium IgG Ab [Titer] in Serum

170

1.53

1.26

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

600

1.27

1.24

1.2

72.9

76.1

titre

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2343

22961

1.09

1.23

6.2

40.6

40.4

mmol/mol

0.33

2129

20812

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

155

1.55

1.23

2.0

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.97

1.22

1.1

1.0

—

(40761535) Cells panel - Urine sediment

259

2297

1.14

1.21

4.4

3.6

—

(3009508) Creatinine [Moles/volume] in Urine

870

8214

1.08

1.21

3.1

6.7

7.1

mmol/l

1.50

710

6772

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

197

1.48

1.19

1.2

1.1

—

(3048879) Bone marrow aspiration report

1.75

1.19

2.1

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

125

1.60

1.17

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

125

1.60

1.17

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

623

1.26

1.17

2.8

3.1

541.2

1079.2

u/ml

0.51

567

(3012516) Albumin [Mass/volume] in Urine

851

8038

1.08

1.17

3.1

3.2

747.4

335.3

mg/l

1.17

527

4959

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

534

1.28

1.17

1.5

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

248

1.42

1.16

1.8

1.4

13055.1

150542.0

e6/l

1.73

169

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.50

1.15

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

1.55

1.14

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

1.55

1.14

1.3

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

492

1.29

1.14

1.3

1.5

10.0

25.0

e6/l

0.62

386

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

183

1.48

1.13

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

493

1.28

1.12

1.4

1.6

1303.3

952.4

e6/l

0.16

408

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

875

0.80

1.11

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

143

1.54

1.11

2.0

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

792

0.79

1.06

5.6

4.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.76

1.06

1.7

1.4

17.6

12.4

g/l

—

(3044290) Cell count panel - Cerebral spinal fluid

453

1.29

1.06

1.2

1.5

—

(3011436) Histone Ab [Units/volume] in Serum

1.93

1.06

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

129

1.55

1.05

1.2

1.6

1.5

1.9

u/field

0.16

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.27

1.03

1.0

103.0

28.1

u/ml

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

106

1.61

1.02

1.4

1.1

1.0

1.1

ratio

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.88

1.00

1.6

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

123

1.55

0.99

1.2

1.4

4.7

6.9

u/l

1.60

102

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.67

0.97

1.3

1.6

54.9

109.2

umol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

451

1.27

0.96

1.4

1.3

39.7

36.5

iu/l

0.23

383

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

496

1.26

0.96

1.3

3.7

3.8

mmol/l

0.43

461

(1617658) Protocol used for examination of sentinel lymph nodes

223

0.63

0.96

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

355

1.30

0.94

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

340

0.70

0.94

1.3

1.1

422.2

47.2

iu/ml

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.78

0.94

1.3

1.1

96.8

100.1

0.12

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.22

0.93

1.8

18.6

19.3

umol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

109

1.56

0.93

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.15

0.91

2.5

2.4

—

15.4

—

(3003694) ABO and Rh group [Type] in Blood

593

6295

0.93

0.91

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.63

0.90

2.4

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

102

1.57

0.90

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

151

1.46

0.90

2.2

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

103

0.48

0.89

1.8

1.4

—

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.69

0.88

2.1

1.5

13.8

15.6

pmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

153

0.59

0.88

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

1.52

0.88

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

137

1.46

0.84

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

111

0.54

0.83

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

111

0.54

0.83

1.2

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

111

0.54

0.83

1.2

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

111

0.54

0.83

1.2

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

113

1.51

0.82

1.4

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

454

0.77

0.81

1.4

1.5

—

(3006462) Nitrate [Presence] in Urine

130

1.46

0.80

5.0

4.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

356

1.27

0.80

1.4

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.79

0.0

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.67

0.78

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

208

1.35

0.77

3.6

5.1

13.9

49.1

u/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

125

0.56

0.77

1.1

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

115

1.48

0.76

1.2

—

(4034850)

811

0.83

0.76

12.1

11.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

591

0.81

0.74

5.4

3.4

30.8

29.2

mg/l

0.10

371

(3028707) Methadone [Presence] in Urine by Screen method

116

1.47

0.74

1.9

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

231

0.69

0.73

1.3

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

100

1.50

0.72

1.3

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

125

1.44

0.72

1.2

2.4

7.6

15.6

umol/l

0.71

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.67

0.72

6.4

9.3

—

(4281824)

298

0.74

0.70

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.55

0.69

1.1

2.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

436

1.22

0.69

1.2

1.3

18.7

43.5

u/l

2.38

374

(3019832) Treponema pallidum Ab [Presence] in Serum

102

891

1.15

0.68

1.6

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2430

24004

1.06

0.68

5.2

5.0

5.9

6.0

mmol/l

7.53

2184

21355

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

144

1.39

0.68

1.0

1.1

0.7

4.5

nmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.63

0.66

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.79

0.66

4.4

5.8

—

(3025130) Human papilloma virus identified in Specimen

197

1.32

0.65

1.8

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

145

1.38

0.65

1.6

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

128

1.41

0.65

1.2

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

171

1.35

0.65

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.59

0.65

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.59

0.65

1.1

1.5

109.7

115.7

ng/l

—

(3013727) Leukocytes other/100 leukocytes in Blood

1.48

0.64

2.5

4.5

40.6

55.1

1.40

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

534

1.18

0.62

1.8

1.9

5.3

4.7

iu/l

0.10

169

(3045414) Leukocytes [Presence] in Urine

132

1183

1.12

0.62

1.8

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

217

1.29

0.61

1.1

2.5

2.6

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.46

0.61

1.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

533

0.82

0.61

2.0

1.4

113.3

222.4

pmol/l

2.28

518

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

236

1.27

0.59

1.4

1.9

—

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.48

0.57

1.1

1.3

—

(3003338) MCHC [Mass/volume]

1917

19478

0.96

0.56

37.5

20.3

329.1

331.6

g/l

26.31

1903

19299

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

247

1.26

0.56

1.5

1.3

6.9

7.6

mmol/l

0.76

167

(4133840)

1.62

0.55

1.5

1.2

—

(40768441) Liver Pathology biopsy report

168

1.31

0.55

1.1

1.4

—

(4211845)

142

1.34

0.54

5.0

3.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.50

0.54

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.48

0.53

1.2

1.1

—

(4024509)

313

1.22

0.53

1.8

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.52

0.52

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.52

0.52

1.1

—

(3020650) Glucose [Presence] in Urine

1.52

0.52

1.1

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.45

0.51

1.1

1.2

37.4

37.1

g/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

875

8481

1.04

0.51

5.4

5.5

3.3

4.2

ug/l

0.47

760

7517

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

135

1.34

0.51

1.6

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.50

2.8

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.50

2.8

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.49

0.49

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

225

1.25

0.49

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

145

1.31

0.48

4.8

6.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.52

0.48

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.47

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.47

0.47

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

1.41

0.46

1.7

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

139

1.30

0.43

2.1

3.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

574

1.14

0.43

1.4

1.3

462.6

529.1

mg/l

0.70

541

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.65

0.42

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.65

0.42

1.2

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.65

0.42

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.64

0.42

1.2

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.43

0.41

6.4

8.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

332

1.18

0.41

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.52

0.41

4.2

5.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.41

0.0

3.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

3.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

210

1975

1.07

0.39

1.5

1.7

1.5

0.79

175

1689

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

269

1.19

0.39

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

326

1.17

0.38

2.2

2.0

32.4

1341.1

u/ml

0.83

316

(40765096) Chromosome analysis panel by Banding

1.33

0.37

1.5

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.62

0.35

1.0

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.40

0.35

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

154

1.24

0.34

2.4

—

(40768793) Breast Pathology biopsy report

635

0.90

0.33

1.3

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.30

0.33

8.7

8.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

164

1.22

0.32

1.3

1.6

14.8

13.4

umol/l

0.33

152

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

120

1288

0.93

0.32

2.6

3.9

57.6

84.9

u/ml

0.78

115

1237

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.33

0.32

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

1.25

0.32

1.9

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

173

1634

1.06

0.31

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

464

0.88

0.31

1.8

1.7

1.0

0.8

nmol/l

1.02

379

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

371

1.13

0.30

1.2

160.6

221.3

miu/ml

0.53

134

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

419

1.12

0.30

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

111

1.26

0.30

1.3

1.4

85.5

65.3

pmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.29

0.30

1.1

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

640

0.90

0.29

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

865

8474

1.03

0.29

4.0

3.9

11.1

8.9

mg/mmol

0.56

508

5219

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

106

0.75

0.29

1.5

1.3

6.0

6.2

mmol/l

—

100

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

107

0.75

0.29

1.8

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.23

0.29

2.0

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

648

0.91

0.28

2.4

1.8

—

(3044941) Cell count panel - Synovial fluid

422

1.12

0.27

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.25

0.27

1.6

1.3

8.5

9.6

ug/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

205

1.17

0.27

1.7

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.23

0.27

1.0

1.1

—

(3004451) EKG impression Narrative

132

1.21

0.25

1.5

1.3

—

(3044007) Cell count panel - Peritoneal fluid

1.22

0.25

1.8

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

315

3046

1.04

0.24

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

101

948

1.07

0.24

1.8

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

297

0.87

0.24

3.2

4.5

348.5

358.3

umol/l

0.12

253

(3024263) Appearance of Synovial fluid

143

1.19

0.23

1.9

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

136

0.81

0.23

2.4

1.6

0.7

1.0

g/l

6.32

136

(3016018) Differential panel - Cerebral spinal fluid

228

1.14

0.22

1.3

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.0

—

7.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

12.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.21

0.0

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.25

0.20

1.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

646

1.07

0.19

2.4

2.2

107.7

76.3

ug/min

0.34

375

(3021387) Prolactin [Units/volume] in Serum or Plasma

367

1.09

0.18

1.9

1.7

285.7

307.2

mu/l

0.23

337

(3016750) Collection duration of Urine

147

1.16

0.18

2.1

1.9

551.5

494.3

min

2.12

105

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

185

1.14

0.18

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

119

1.18

0.17

1.0

1.3

1.2

u/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.15

0.17

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

177

1.13

0.16

2.0

2.8

—

(3051593) INR in Capillary blood by Coagulation assay

158

1.14

0.16

8.2

15.3

—

(4146454)

331

1.09

0.16

2.6

2.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

159

1.13

0.15

1.3

29.7

37.1

u/l

0.26

130

(3037556) Urate [Mass/volume] in Serum or Plasma

0.79

0.14

2.3

1.4

—

(44806420)

0.81

0.13

2.1

2.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

356

0.93

0.13

3.0

2.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

228

1.10

0.13

1.2

1.1

—

4.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

495

4881

1.02

0.12

3.3

0.7

0.8

ug/l

3.13

351

3441

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.15

0.10

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

341

0.94

0.10

1.2

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

238

0.92

0.09

1.4

2.1

1.1

2.0

u/field

—

(3000285) Sodium [Moles/volume] in Blood

1.06

0.09

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

222

2261

0.98

0.09

1.5

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

226

0.93

0.08

2.5

3.1

116.3

24.1

mg/l

0.70

176

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

156

1.09

0.08

1.4

0.4

0.3

nmol/l

0.24

118

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

677

1.03

0.08

2.2

1.7

6.6

2.8

mg/l

1.37

496

(3019150) Specific gravity of Urine by Refractometry

548

5430

1.01

0.08

5.5

4.5

1.0

kg/l

0.24

858

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

127

1.10

0.08

1.6

1.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.03

0.07

1.3

1.1

2225.1

1604.0

miu/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

354

3582

0.99

0.07

10.7

7.3

—

(3022689) Creatine [Moles/volume] in Urine

0.80

0.07

3.0

1.5

—

(40768800) Prostate Pathology biopsy report

550

1.04

0.07

1.2

—

(3015183) Erythrocyte sedimentation rate

0.84

0.07

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.82

0.07

1.1

1.8

1.6

11.5

nmol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.86

0.06

1.9

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2286

22819

1.01

0.05

4.2

1.2

1.3

mmol/l

3.80

2017

20267

(3004775) Volume in Urine collected for unspecified duration

208

1.06

0.05

2.0

2.1

602.1

627.9

0.17

132

(3022621) pH of Urine by Test strip

181

1833

0.99

0.05

3.9

3.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

684

6804

1.01

0.05

4.8

4.7

20.4

22.0

2.15

335

3591

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2443

24462

0.99

0.04

5.3

2.5

2.7

mmol/l

9.39

2200

21987

(3027944) Amphetamines [Presence] in Urine

270

1.04

0.03

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

857

1.02

0.03

1.7

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

209

0.96

0.03

1.0

38.5

46.3

ng/l

0.55

127

(3000764) Benzodiazepines [Presence] in Urine

271

1.03

0.02

1.6

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

208

0.96

0.02

1.0

738.9

669.4

ng/l

0.26

125

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

208

0.96

0.02

1.0

330.1

326.9

ng/l

0.02

129

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2384

23857

1.00

0.02

4.8

4.7

4.5

4.6

mmol/l

4.95

2153

21570

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2365

23636

1.00

0.01

4.7

1.5

mmol/l

1.53

2117

21199

(3027008) Opiates [Presence] in Urine

273

1.03

0.01

1.6

1.7

—

(3016879) Cocaine [Presence] in Urine

254

1.02

0.00

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

274

1.02

0.00

1.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

222

0.99

0.00

1.8

10994.8

1844.0

u/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

593

0.99

0.00

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

193

0.98

0.00

1.7

2.0

2.4

3.3

ug/l

0.80

170

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.01

0.00

1.1

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

2.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.86

0.00

2.0

1.3

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.9

—

403.3

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.92

0.00

1.7

2.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

13.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.98

0.00

1.0

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_BRONCHIECTASIS and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_BRONCHIECTASIS	1.545 [1.4, 1.7]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.26

During the follow-up period (1.1.1998 — 31.12.2019), 1891 out of 7086 females with J10_BRONCHIECTASIS died.

Males

Parameter	HR [95% CI]	p-value
J10_BRONCHIECTASIS	1.732 [1.55, 1.94]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.047

During the follow-up period (1.1.1998 — 31.12.2019), 2027 out of 5373 males with J10_BRONCHIECTASIS died.

Mortality risk

Mortality risk for people of age

years, who have J10_BRONCHIECTASIS.

N-year risk	Females	Males
1	0.149%	0.35%
5	0.891%	2.106%
10	2.296%	5.365%
15	4.16%	9.995%
20	7.387%	17.149%

Relationships between endpoints

↥

Index endpoint: J10_BRONCHIECTASIS – Bronchiectasis

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bronchiectasis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints